Thrombin-induced	B-protein
p65	I-protein
homodimer	I-protein
binding	O
to	O
downstream	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
of	O
the	O
promoter	O
mediates	O
endothelial	O
ICAM-1	B-protein
expression	O
and	O
neutrophil	B-cell_type
adhesion	O
.	O

We	O
investigated	O
the	O
mechanisms	O
by	O
which	O
proinflammatory	B-protein
mediator	I-protein
,	O
thrombin	B-protein
,	O
released	O
during	O
intravascular	O
coagulation	O
and	O
tissue	O
injury	O
,	O
induces	O
ICAM-1	B-protein
(	O
CD54	B-protein
)	O
expression	O
in	O
endothelial	B-cell_type
cells	I-cell_type
.	O

Stimulation	O
of	O
HUVEC	B-cell_line
with	O
thrombin	B-protein
resulted	O
in	O
dose-	O
and	O
time-dependent	O
increases	O
in	O
ICAM-1	B-RNA
mRNA	I-RNA
and	O
cell	O
surface	O
expression	O
and	O
in	O
ICAM-1	B-protein
-dependent	O
endothelial	O
adhesivity	O
toward	O
polymorphonuclear	B-cell_type
leukocytes	I-cell_type
.	O

Transient	O
transfection	O
of	O
endothelial	B-cell_type
cells	I-cell_type
with	O
ICAM-1	B-DNA
promoter	I-DNA
luciferase	I-DNA
reporter	I-DNA
gene	I-DNA
(	I-DNA
ICAM-1LUC	I-DNA
)	I-DNA
constructs	I-DNA
indicated	O
that	O
deletion	O
of	O
upstream	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
(	O
-533	B-DNA
bases	I-DNA
from	O
translation	B-DNA
start	I-DNA
site	I-DNA
)	O
had	O
no	O
effect	O
on	O
thrombin	B-protein
responsiveness	O
,	O
whereas	O
mutation/deletion	O
of	O
downstream	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
(	O
-223	B-DNA
bases	I-DNA
from	O
the	O
translation	B-DNA
start	I-DNA
site	I-DNA
)	O
prevented	O
the	O
activation	O
of	O
ICAM-1	B-DNA
promoter	I-DNA
,	O
indicating	O
that	O
the	O
downstream	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
is	O
critical	O
for	O
thrombin	B-protein
inducibility	O
.	O

NF-kappa	B-protein
B	I-protein
-directed	O
luciferase	B-protein
activity	O
increased	O
approximately	O
3-fold	O
when	O
cells	O
transfected	O
with	O
the	O
plasmid	B-DNA
pNF-kappa	I-DNA
BLUC	I-DNA
containing	O
five	O
copies	O
of	O
consensus	B-DNA
NF-kappa	I-DNA
B	I-DNA
site	I-DNA
linked	O
to	O
a	O
minimal	O
adenovirus	B-DNA
E1B	I-DNA
promoter-luciferase	I-DNA
gene	I-DNA
were	O
exposed	O
to	O
thrombin	B-protein
,	O
indicating	O
that	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
was	O
essential	O
for	O
thrombin	B-protein
response	O
.	O

Gel	O
supershift	O
assays	O
demonstrated	O
that	O
thrombin	B-protein
induced	O
binding	O
of	O
NF-kappa	B-protein
Bp65	I-protein
(	O
Rel	B-protein
A	I-protein
)	O
to	O
downstream	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
of	O
the	O
ICAM-1	B-DNA
promoter	I-DNA
.	O

Thrombin	B-protein
receptor	O
activation	O
peptide	O
,	O
a	O
14-amino-acid	O
peptide	O
representing	O
the	O
new	O
NH2	B-protein
terminus	I-protein
of	O
proteolytically	O
activated	O
receptor-1	B-protein
,	O
mimicked	O
thrombin	B-protein
's	O
action	O
in	O
inducing	O
ICAM-1	B-protein
expression	O
.	O

These	O
data	O
indicate	O
that	O
thrombin	B-protein
activates	O
endothelial	O
ICAM-1	B-protein
expression	O
and	O
polymorphonuclear	B-cell_type
leukocyte	I-cell_type
adhesion	O
by	O
NF-kappa	B-protein
Bp65	I-protein
binding	O
to	O
the	O
downstream	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
of	O
ICAM-1	B-DNA
promoter	I-DNA
after	O
proteolytically	O
activated	O
receptor-1	O
activation	O
.	O

x	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
Sa	NULL
meJournal	NULL
f	NULL
Thrombin-Induced	NULL
p65	NULL
Homodimer	NULL
Binding	NULL
'	NULL
Immunolo	NULL
gy	NULL
to	NULL
Downstream	NULL
NF-	NULL
KB	NULL
Site	NULL
of	NULL
the	NULL
Promoter	NULL
Mediates	NULL
Endothelial	NULL
ICAM-1	NULL
Expression	NULL
and	NULL
Neutrophil	NULL
Adhesion	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Arshad	NULL
Rahman	NULL
,	NULL
Khandaker	NULL
N.	NULL
Anwar	NULL
,	NULL
Andrea	NULL
L.	NULL
True	NULL
and	NULL
Asrar	NULL
B.	NULL
Malik	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:5466-5476	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/9/5466	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
51	NULL
articles	NULL
,	NULL
21	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/9/5466.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Thrombin-Induced	NULL
p65	NULL
Homodimer	NULL
Binding	NULL
to	NULL
Downstream	NULL
NF-B	NULL
Site	NULL
of	NULL
the	NULL
Promoter	NULL
Mediates	NULL
Endothelial	NULL
ICAM-1	NULL
Expression	NULL
and	NULL
Neutrophil	NULL
Adhesion	NULL
'	NULL
Arshad	NULL
Rahman	NULL
,	NULL
``	NULL
Khandaker	NULL
N.	NULL
Anwar	NULL
,	NULL
Andrea	NULL
L.	NULL
True	NULL
,	NULL
and	NULL
Asrar	NULL
B.	NULL
Malik	NULL
We	NULL
investigated	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
proinflammatory	NULL
mediator	NULL
,	NULL
thrombin	NULL
,	NULL
released	NULL
during	NULL
intravascular	NULL
coagulation	NULL
and	NULL
tissue	NULL
injury	NULL
,	NULL
induces	NULL
ICAM-1	NULL
(	NULL
CD54	NULL
)	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Stimulation	NULL
of	NULL
HUVEC	NULL
with	NULL
thrombin	NULL
resulted	NULL
in	NULL
dose-	NULL
and	NULL
time-dependent	NULL
increases	NULL
in	NULL
ICAM-1	NULL
mRNA	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
and	NULL
in	NULL
ICAM-1-dependent	NULL
endothelial	NULL
adhesivity	NULL
toward	NULL
polymorphonuclear	NULL
leukocytes	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
endothelial	NULL
cells	NULL
with	NULL
ICAM-1	NULL
promoter	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
ICAM-1LUC	NULL
)	NULL
constructs	NULL
indicated	NULL
that	NULL
deletion	NULL
of	NULL
upstream	NULL
site	NULL
(	NULL
-533	NULL
bases	NULL
from	NULL
translation	NULL
start	NULL
site	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
thrombin	NULL
responsiveness	NULL
,	NULL
whereas	NULL
mutation/deletion	NULL
of	NULL
downstream	NULL
NF-KB	NULL
site	NULL
(	NULL
-223	NULL
bases	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
)	NULL
prevented	NULL
the	NULL
activation	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
thrombin	NULL
inducibility	NULL
.	NULL

luciferase	NULL
activity	NULL
increased	NULL
~3-fold	NULL
when	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
plasmid	NULL
pNF-	NULL
«	NULL
BLUC	NULL
containing	NULL
five	NULL
copies	NULL
of	NULL
consensus	NULL
NF-KB	NULL
site	NULL
linked	NULL
to	NULL
a	NULL
minimal	NULL
adenovirus	NULL
E1B	NULL
promoter-luciferase	NULL
gene	NULL
were	NULL
exposed	NULL
to	NULL
thrombin	NULL
,	NULL
indicating	NULL
that	NULL
activation	NULL
of	NULL
NF-xB	NULL
was	NULL
essential	NULL
for	NULL
thrombin	NULL
response	NULL
.	NULL

Gel	NULL
supershift	NULL
assays	NULL
demonstrated	NULL
that	NULL
thrombin	NULL
induced	NULL
binding	NULL
of	NULL
NF-Bp65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
to	NULL
downstream	NULL
site	NULL
of	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
.	NULL

Thrombin	NULL
receptor	NULL
activation	NULL
peptide	NULL
,	NULL
a	NULL
14-amino-acid	NULL
peptide	NULL
representing	NULL
the	NULL
new	NULL
NH	NULL
,	NULL
terminus	NULL
of	NULL
proteolytically	NULL
activated	NULL
receptor-1	NULL
,	NULL
mimicked	NULL
thrombin	NULL
's	NULL
action	NULL
in	NULL
inducing	NULL
ICAM-1	NULL
expression	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
thrombin	NULL
activates	NULL
endothelial	NULL
ICAM-1	NULL
expression	NULL
and	NULL
polymorphonuclear	NULL
leukocyte	NULL
adhesion	NULL
by	NULL
NF-binding	NULL
to	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
after	NULL
proteolytically	NULL
activated	NULL
receptor-1	NULL
activation	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
5466-5476.	NULL
hrombin	NULL
,	NULL
a	NULL
serine	NULL
protease	NULL
derived	NULL
from	NULL
the	NULL
zymogen	NULL
pro	NULL
thrombin	NULL
,	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
hemostasis	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
func-	NULL
tions	NULL
as	NULL
an	NULL
agonist	NULL
for	NULL
responses	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

In	NULL
endothelial	NULL
cells	NULL
,	NULL
the	NULL
responses	NULL
of	NULL
thrombin	NULL
can	NULL
be	NULL
classified	NULL
into	NULL
two	NULL
general	NULL
categories	NULL
,	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
activation	NULL
.	NULL

Type	NULL
I	NULL
activation	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
includes	NULL
the	NULL
events	NULL
that	NULL
occur	NULL
rapidly	NULL
and	NULL
are	NULL
independent	NULL
of	NULL
protein	NULL
synthesis	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

Type	NULL
II	NULL
activation	NULL
(	NULL
6	NULL
)	NULL
refers	NULL
to	NULL
delayed	NULL
events	NULL
that	NULL
are	NULL
protein	NULL
synthesis	NULL
dependent	NULL
and	NULL
are	NULL
transcriptionally	NULL
regulated	NULL
(	NULL
11-15	NULL
)	NULL
.	NULL

Thrombin	NULL
mediates	NULL
most	NULL
of	NULL
its	NULL
responses	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
PAR-1	NULL
``	NULL
that	NULL
belongs	NULL
to	NULL
a	NULL
new	NULL
family	NULL
of	NULL
protease-activated	NULL
receptors	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

PAR-1	NULL
has	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
activation	NULL
as	NULL
thrombin	NULL
binds	NULL
to	NULL
the	NULL
extracellular	NULL
NH	NULL
,	NULL
-terminal	NULL
,	NULL
hirudin-like	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
53-64	NULL
)	NULL
of	NULL
the	NULL
receptor	NULL
and	NULL
catalyzes	NULL
receptor	NULL
proteolysis	NULL
between	NULL
arginine-41	NULL
and	NULL
serine-42	NULL
(	NULL
16	NULL
)	NULL
.	NULL

This	NULL
enzy-matic	NULL
event	NULL
unmasks	NULL
a	NULL
tethered	NULL
ligand	NULL
that	NULL
interacts	NULL
within	NULL
sequences	NULL
corresponding	NULL
to	NULL
extracellular	NULL
loop	NULL
2	NULL
(	NULL
amino	NULL
acid	NULL
248-	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Illinois	NULL
,	NULL
Chicago	NULL
,	NULL
TL	NULL
60612	NULL
Received	NULL
for	NULL
publication	NULL
July	NULL
31	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
February	NULL
9	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
HL27016	NULL
,	NULL
HL46350	NULL
,	NULL
and	NULL
HL45638	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Arshad	NULL
Rahman	NULL
,	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Illinois	NULL
,	NULL
835	NULL
South	NULL
Wolcott	NULL
Av-enue	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60612-7343	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
ARahman	NULL
@	NULL
uic.edu	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PAR-1	NULL
,	NULL
protease-activated	NULL
receptor-1	NULL
;	NULL
C/EBP	NULL
,	NULL
CAAT	NULL
enhancer-binding	NULL
protein	NULL
;	NULL
CHX	NULL
,	NULL
cycloheximide	NULL
;	NULL
COX-2	NULL
,	NULL
cyclooxygenase-2	NULL
;	NULL
EGM	NULL
,	NULL
endothelial	NULL
growth	NULL
medium	NULL
;	NULL
IB	NULL
,	NULL
inhibitory	NULL
protein-kB	NULL
;	NULL
LUC	NULL
,	NULL
luciferase	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidinedithio-carbamate	NULL
;	NULL
PMN	NULL
,	NULL
polymorphonuclear	NULL
leukocyte	NULL
;	NULL
RLU	NULL
,	NULL
relative	NULL
light	NULL
unit	NULL
;	NULL
Sp-1	NULL
,	NULL
promoter	NULL
selective-1	NULL
;	NULL
TRAP	NULL
,	NULL
thrombin	NULL
receptor	NULL
activation	NULL
pep-tide	NULL
;	NULL
TRE	NULL
,	NULL
tetradecanoylphorbol-13-acetate	NULL
responsive	NULL
element	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
268	NULL
)	NULL
of	NULL
the	NULL
receptor	NULL
(	NULL
18	NULL
)	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
activates	NULL
thrombin	NULL
's	NULL
cellular	NULL
responses	NULL
.	NULL

Thrombin	NULL
receptor	NULL
activation	NULL
peptide	NULL
(	NULL
TRAP	NULL
;	NULL
SFLLRNPNDKYEPF	NULL
)	NULL
,	NULL
a	NULL
14-amino-acid	NULL
peptide	NULL
corresponding	NULL
to	NULL
the	NULL
newly	NULL
exposed	NULL
tethered	NULL
ligand	NULL
,	NULL
reproduces	NULL
many	NULL
of	NULL
the	NULL
cellular	NULL
responses	NULL
characteristic	NULL
of	NULL
native	NULL
thrombin	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Studies	NULL
have	NULL
shown	NULL
that	NULL
thrombin	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
polymorphonuclear	NULL
leukocyte	NULL
(	NULL
PMN	NULL
)	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
basis	NULL
of	NULL
increased	NULL
endothelial	NULL
adhesivity	NULL
may	NULL
involve	NULL
type	NULL
I	NULL
activation	NULL
of	NULL
adhesive	NULL
proteins	NULL
such	NULL
as	NULL
ICAM-1	NULL
(	NULL
CD54	NULL
)	NULL
on	NULL
the	NULL
endothelial	NULL
cell	NULL
surface	NULL
.	NULL

However	NULL
,	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
indicating	NULL
that	NULL
thrombin	NULL
mediates	NULL
type	NULL
II	NULL
activation	NULL
of	NULL
ICAM-1	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
ICAM-1	NULL
with	NULL
its	NULL
counter-receptors	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
leukocytes	NULL
,	NULL
CD11a/CD18	NULL
and	NULL
CD11b/CD18	NULL
B	NULL
;	NULL
integrins	NULL
,	NULL
is	NULL
a	NULL
critical	NULL
requirement	NULL
for	NULL
PMN	NULL
adhesion	NULL
and	NULL
transendothelial	NULL
PMN	NULL
migration	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

ICAM-1	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
low	NULL
levels	NULL
,	NULL
but	NULL
its	NULL
expression	NULL
can	NULL
be	NULL
transcriptionally	NULL
up-regulated	NULL
by	NULL
cytokines	NULL
via	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
21-23	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factors	NULL
are	NULL
composed	NULL
of	NULL
five	NULL
distinct	NULL
DNA-binding	NULL
subunits	NULL
,	NULL
called	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
Rel-B	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
different	NULL
family	NULL
members	NULL
can	NULL
associate	NULL
in	NULL
various	NULL
homo-	NULL
or	NULL
heterodimers	NULL
through	NULL
a	NULL
highly	NULL
conserved	NULL
NH-terminal	NULL
sequence	NULL
,	NULL
NRD	NULL
(	NULL
NF-	NULL
«	NULL
B/rel/Dorsal	NULL
)	NULL
(	NULL
25	NULL
)	NULL
or	NULL
Rel	NULL
ho-mology	NULL
domain	NULL
.	NULL

Inactive	NULL
NF-KB	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
the	NULL
inhibitory	NULL
protein	NULL
I-	NULL
«	NULL
B	NULL
(	NULL
IB	NULL
)	NULL
and	NULL
released	NULL
after	NULL
phosphorylation	NULL
of	NULL
IB	NULL
either	NULL
on	NULL
serine	NULL
residues	NULL
32	NULL
and	NULL
36	NULL
of	NULL
IxBa	NULL
and	NULL
serines	NULL
19	NULL
and	NULL
23	NULL
of	NULL
IxBB	NULL
by	NULL
IB	NULL
kinases	NULL
a	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
,	NULL
that	NULL
regulates	NULL
their	NULL
ubiquitin-dependent	NULL
degradation	NULL
through	NULL
the	NULL
26S	NULL
proteasome	NULL
(	NULL
28-31	NULL
)	NULL
,	NULL
or	NULL
on	NULL
tyrosine	NULL
residues	NULL
of	NULL
that	NULL
does	NULL
not	NULL
involve	NULL
its	NULL
degradation	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
dimer	NULL
then	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
regulates	NULL
transcription	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
ICAM-1	NULL
involved	NULL
in	NULL
inflammatory	NULL
responses	NULL
(	NULL
33-35	NULL
)	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
-1290	NULL
-940	NULL
-865	NULL
-533	NULL
FIGURE	NULL
1	NULL
.	NULL

410	NULL
-	NULL
-321	NULL
-243	NULL
-237	NULL
-223	NULL
-	NULL
-84	NULL
5467	NULL
AIG	NULL
_	NULL
Schematic	NULL
diagram	NULL
of	NULL
5	NULL
'	NULL
regulatory	NULL
region	NULL
of	NULL
human	NULL
ICAM-1	NULL
gene	NULL
.	NULL

Rectangles	NULL
indicate	NULL
the	NULL
location	NULL
of	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
tran	NULL
scription	NULL
factors	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
AP-3	NULL
,	NULL
Ets	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
TRE	NULL
,	NULL
Sp-1	NULL
,	NULL
and	NULL
C/EBP	NULL
.	NULL

The	NULL
arrow	NULL
above	NULL
the	NULL
initiation	NULL
codon	NULL
ATG	NULL
indicates	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
has	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
36	NULL
)	NULL
:	NULL
the	NULL
upstream	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
5'-CGGGAGGATTCCTGGGCC-3	NULL
'	NULL
,	NULL
element	NULL
underlined	NULL
,	NULL
within	NULL
-542	NULL
to	NULL
-524	NULL
bases	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
)	NULL
and	NULL
the	NULL
downstream	NULL
NF-KB	NULL
(	NULL
5	NULL
element	NULL
underlined	NULL
,	NULL
within	NULL
-231	NULL
to	NULL
-211	NULL
bases	NULL
from	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
thrombin-induced	NULL
expression	NULL
of	NULL
ICAM-1	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
tran-scription	NULL
,	NULL
and	NULL
that	NULL
this	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
Bp65	NULL
to	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
evidence	NULL
linking	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
procoagulant	NULL
,	NULL
thrombin	NULL
,	NULL
to	NULL
induction	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
culture	NULL
HUVEC	NULL
were	NULL
obtained	NULL
from	NULL
Clonetics	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
grown	NULL
on	NULL
gel-atin-coated	NULL
flasks	NULL
or	NULL
plates	NULL
in	NULL
endothelial	NULL
cell	NULL
growth	NULL
medium	NULL
(	NULL
EGM	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
3	NULL
mg/m	NULL
!	NULL

of	NULL
endothelial-derived	NULL
growth	NULL
factor	NULL
from	NULL
bovine	NULL
brain	NULL
extract	NULL
protein	NULL
.	NULL

Human	NULL
thrombin	NULL
with	NULL
an	NULL
activity	NULL
of	NULL
3170	NULL
NIH	NULL
U/mg	NULL
protein	NULL
was	NULL
purchased	NULL
from	NULL
Enzyme	NULL
Research	NULL
Laboratories	NULL
(	NULL
South	NULL
Bend	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

All	NULL
experiments	NULL
,	NULL
except	NULL
where	NULL
indicated	NULL
,	NULL
were	NULL
made	NULL
using	NULL
cells	NULL
under	NULL
eighth	NULL
passage	NULL
.	NULL

Eahy926	NULL
cells	NULL
,	NULL
a	NULL
hybrid	NULL
cell	NULL
line	NULL
of	NULL
HUVEC	NULL
and	NULL
A549	NULL
cell	NULL
line	NULL
(	NULL
derived	NULL
from	NULL
human	NULL
lung	NULL
epithelial	NULL
type	NULL
II	NULL
cells	NULL
)	NULL
,	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
C.	NULL
J.	NULL
Edgell	NULL
(	NULL
University	NULL
of	NULL
North	NULL
Carolina	NULL
,	NULL
Chapel	NULL
Hill	NULL
)	NULL
and	NULL
cultured	NULL
as	NULL
described	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Eahy926	NULL
cells	NULL
retain	NULL
endothelial	NULL
morphology	NULL
and	NULL
express	NULL
endothelial	NULL
cell-specific	NULL
marker	NULL
human	NULL
factor	NULL
VIII-related	NULL
Ag	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
upon	NULL
stimulation	NULL
with	NULL
TNF-	NULL
«	NULL
these	NULL
cells	NULL
also	NULL
express	NULL
the	NULL
endothelial	NULL
cell-specific	NULL
adhesion	NULL
molecule	NULL
E-selectin	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Confluent	NULL
HUVEC	NULL
or	NULL
Eahy926	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
2	NULL
h	NULL
in	NULL
EGM	NULL
containing	NULL
1-2	NULL
%	NULL
FCS	NULL
or	NULL
in	NULL
RPMI	NULL
containing	NULL
0.5	NULL
%	NULL
FCS	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
with	NULL
thrombin	NULL
or	NULL
TRAP	NULL
for	NULL
the	NULL
times	NULL
and	NULL
at	NULL
concentrations	NULL
indicated	NULL
in	NULL
each	NULL
experiment	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
HUVEC	NULL
with	NULL
RNeasy	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Chats-worth	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Quantification	NULL
and	NULL
purity	NULL
of	NULL
RNA	NULL
were	NULL
assessed	NULL
by	NULL
absorption	NULL
,	NULL
and	NULL
an	NULL
aliquot	NULL
of	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
from	NULL
samples	NULL
with	NULL
ratio	NULL
above	NULL
1.6	NULL
was	NULL
fractionated	NULL
using	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
formaldehyde	NULL
gel	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
Duralose-UV	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
covalently	NULL
linked	NULL
by	NULL
UV	NULL
irradiation	NULL
using	NULL
a	NULL
Stratalinker	NULL
UV	NULL
cross-linker	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Human	NULL
ICAM-1	NULL
(	NULL
0.96-kb	NULL
Sall	NULL
to	NULL
Psfl	NULL
fragment	NULL
)	NULL
(	NULL
40	NULL
)	NULL
and	NULL
rat	NULL
GAPDH	NULL
(	NULL
1.1-kb	NULL
Psfl	NULL
fragment	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-*	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
using	NULL
the	NULL
random	NULL
primer	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
and	NULL
hybridization	NULL
was	NULL
conducted	NULL
as	NULL
described	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
prehybridized	NULL
for	NULL
30	NULL
min	NULL
at	NULL
68°C	NULL
in	NULL
QuikHyb	NULL
solution	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
hybridized	NULL
for	NULL
2	NULL
h	NULL
at	NULL
68°C	NULL
with	NULL
random	NULL
primed	NULL
*°P-la-beled	NULL
probes	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
washed	NULL
twice	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
2X	NULL
SSC	NULL
with	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
followed	NULL
by	NULL
two	NULL
washes	NULL
for	NULL
15	NULL
min	NULL
each	NULL
at	NULL
60°C	NULL
in	NULL
0.1X	NULL
SSC	NULL
with	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
at	NULL
-70°C	NULL
for	NULL
12-24	NULL
h.	NULL
The	NULL
signal	NULL
intensities	NULL
were	NULL
quantified	NULL
by	NULL
scanning	NULL
the	NULL
autoradiograms	NULL
with	NULL
a	NULL
laser	NULL
densitometer	NULL
(	NULL
Howtek	NULL
,	NULL
Hudson	NULL
,	NULL
NH	NULL
)	NULL
linked	NULL
to	NULL
a	NULL
computer	NULL
analysis	NULL
system	NULL
(	NULL
PDI	NULL
Imageware	NULL
Systems	NULL
,	NULL
Huntington	NULL
Station	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
nitrocellulose	NULL
membrane	NULL
was	NULL
soaked	NULL
for	NULL
stripping	NULL
the	NULL
probe	NULL
with	NULL
boiled	NULL
water	NULL
containing	NULL
0.1X	NULL
SSC	NULL
with	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Reporter	NULL
gene	NULL
constructs	NULL
,	NULL
endothelial	NULL
cell	NULL
transfection	NULL
,	NULL
and	NULL
luciferase	NULL
assay	NULL
The	NULL
ICAM-1LUC	NULL
reporter	NULL
plasmid	NULL
and	NULL
its	NULL
5°	NULL
deletion	NULL
derivatives	NULL
have	NULL
been	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
containing	NULL
~600	NULL
bp	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
with	NULL
wild-type	NULL
(	NULL
pGL2-WT	NULL
)	NULL
and	NULL
mutated	NULL
versions	NULL
of	NULL
Sp-1	NULL
(	NULL
pGL2-	NULL
Sp-1-MU	NULL
,	NULL
C/EBP	NULL
(	NULL
pGL2-C/EBP-MU	NULL
)	NULL
,	NULL
and	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
pGL2-NF-	NULL
«	NULL
B-MU	NULL
)	NULL
(	NULL
22	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
Z.	NULL
Cao	NULL
(	NULL
Tularik	NULL
,	NULL
San	NULL
Fran-cisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pNF-	NULL
«	NULL
BLUC	NULL
containing	NULL
five	NULL
copies	NULL
of	NULL
consensus	NULL
NF-KB	NULL
site	NULL
linked	NULL
to	NULL
a	NULL
minimal	NULL
E1B	NULL
promoter-luciferase	NULL
reporter	NULL
gene	NULL
was	NULL
purchased	NULL
from	NULL
Stratagene	NULL
.	NULL

HUVEC	NULL
under	NULL
the	NULL
fifth	NULL
passage	NULL
or	NULL
Eahy926	NULL
cells	NULL
were	NULL
plated	NULL
into	NULL
six-well	NULL
Primaria	NULL
culture	NULL
dishes	NULL
18-24	NULL
h	NULL
before	NULL
transfection	NULL
.	NULL

Transfections	NULL
of	NULL
HUVEC	NULL
(	NULL
except	NULL
for	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
were	NULL
performed	NULL
using	NULL
superfect	NULL
(	NULL
Qiagen	NULL
)	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Briefly	NULL
,	NULL
reporter	NULL
DNA	NULL
(	NULL
1	NULL
pug	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
5-7.5	NULL
ul	NULL
of	NULL
superfect	NULL
in	NULL
100	NULL
pl	NULL
serum-free	NULL
EGM	NULL
(	NULL
Clonetics	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

We	NULL
used	NULL
0.2	NULL
ug	NULL
pTKRLUC	NULL
plasmid	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
containing	NULL
Renilla	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
constitutively	NULL
active	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
to	NULL
normalize	NULL
transfection	NULL
efficiencies	NULL
.	NULL

Since	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
significant	NULL
difference	NULL
in	NULL
transfection	NULL
efficiencies	NULL
in	NULL
the	NULL
initial	NULL
experiments	NULL
,	NULL
we	NULL
did	NULL
not	NULL
cotransfect	NULL
the	NULL
pTKRLUC	NULL
construct	NULL
in	NULL
the	NULL
later	NULL
experiments	NULL
.	NULL

After	NULL
a	NULL
5-10-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
0.6	NULL
ml	NULL
EGM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
applied	NULL
onto	NULL
the	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
.	NULL

Two	NULL
to	NULL
three	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
changed	NULL
to	NULL
EGM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
confluency	NULL
.	NULL

Using	NULL
this	NULL
protocol	NULL
,	NULL
we	NULL
achieved	NULL
a	NULL
transient	NULL
transfection	NULL
efficiency	NULL
of	NULL
11	NULL
+	NULL
2	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SD	NULL
;	NULL
r	NULL
=	NULL
3	NULL
)	NULL
for	NULL
HUVEC	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
transfection	NULL
efficiency	NULL
,	NULL
HUVEC	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
expression	NULL
plasmid	NULL
pGreen	NULL
Lantern-1	NULL
containing	NULL
green	NULL
fluorescence	NULL
protein	NULL
gene	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
FACS	NULL
analysis	NULL
for	NULL
green	NULL
fluorescence	NULL
protein	NULL
expression	NULL
to	NULL
determine	NULL
the	NULL
transfection	NULL
effi-ciency	NULL
.	NULL

For	NULL
transfection	NULL
of	NULL
Eahy926	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
lipofectamine	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
as	NULL
described	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
reporter	NULL
DNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
2	NULL
ul	NULL
of	NULL
lipofectamine	NULL
in	NULL
200	NULL
gl	NULL
of	NULL
Opti-MEM	NULL
I	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

After	NULL
a	NULL
30-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
Opti-MEM	NULL
I	NULL
(	NULL
800	NULL
pl	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
applied	NULL
onto	NULL
the	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
washed	NULL
twice	NULL
with	NULL
Opti-MEM	NULL
I	NULL
.	NULL

Three	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
changed	NULL
to	NULL
RPMI	NULL
containing	NULL
10	NULL
%	NULL
serum	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
confluency	NULL
.	NULL

Twelve	NULL
to	NULL
18	NULL
h	NULL
before	NULL
harvesting	NULL
cells	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
replaced	NULL
with	NULL
EGM	NULL
containing	NULL
1	NULL
%	NULL
FCS	NULL
or	NULL
RPMI	NULL
containing	NULL
0.1	NULL
%	NULL
FCS	NULL
,	NULL
for	NULL
HUVEC	NULL
and	NULL
Eahy926	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
thrombin	NULL
(	NULL
2.5	NULL
or	NULL
5	NULL
U/ml	NULL
)	NULL
or	NULL
TRAP	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
.	NULL

Cell	NULL
extract	NULL
was	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
Promega	NULL
Biotech	NULL
dual	NULL
luciferase	NULL
repoter	NULL
assay	NULL
system	NULL
either	NULL
by	NULL
TD	NULL
20/20	NULL
luminometer	NULL
(	NULL
Turner	NULL
Designs	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
Monolight	NULL
2010	NULL
lumionmeter	NULL
(	NULL
Analytical	NULL
Luminiscence	NULL
Laboratory	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
.	NULL

Firefly	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
and	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
/ug	NULL
of	NULL
cell	NULL
protein	NULL
.	NULL

The	NULL
protein	NULL
content	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
Bio-Rad	NULL
protein	NULL
determination	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
After	NULL
appropriate	NULL
treatments	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
400	NULL
ul	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
.	NULL

After	NULL
15	NULL
min	NULL
,	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.6	NULL
%	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
centrifuged	NULL
and	NULL
supernatants	NULL
containing	NULL
the	NULL
nuclear	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
new	NULL
vials	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
extract	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
Bio-Rad	NULL
protein	NULL
determination	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
EMSA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HC	NULL
]	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
(	NULL
20	NULL
pl	NULL
final	NULL
volume	NULL
)	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Then	NULL
end-labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
(	NULL
30,000	NULL
cpm	NULL
each	NULL
)	NULL
were	NULL
added	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
25-	NULL
or	NULL
100-fold	NULL
molar	NULL
excess	NULL
cold	NULL
competitor	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
Ab	NULL
supershift	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5468	NULL
a	NULL
&	NULL
0	NULL
NYJ	NULL
-	NULL
-__	NULL
_	NULL
___	NULL
sagen	NULL
Thrombin	NULL
(	NULL
3	NULL
h	NULL
)	NULL
©	NULL
Control	NULL
a	NULL
9	NULL
cg	NULL
u	NULL
8g	NULL
®	NULL
=	NULL
9	NULL
8	NULL
&	NULL
a	NULL
@	NULL
0	NULL
o	NULL
f	NULL
10°	NULL
10	NULL
'	NULL
10	NULL
10°	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
o	NULL
to	NULL
0	NULL
M	NULL
MY	NULL
O00	NULL
000	NULL
aes	NULL
Thrombin	NULL
(	NULL
12	NULL
h	NULL
)	NULL
$	NULL
3	NULL
Control	NULL
o	NULL
0	NULL
3	NULL
g	NULL
to	NULL
8	NULL
$	NULL
4	NULL
=	NULL
9	NULL
@	NULL
``	NULL
7	NULL
o	NULL
o	NULL
§4	NULL
23	NULL
o	NULL
3	NULL
r	NULL
--	NULL
me-	NULL
--	NULL
-	NULL
.	NULL

10	NULL
10	NULL
10	NULL
10	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
o	NULL
d	NULL
Q4	NULL
|	NULL
0000000	NULL
mees	NULL
TNFa	NULL
(	NULL
12	NULL
h	NULL
)	NULL
g	NULL
3	NULL
Control	NULL
a	NULL
&	NULL
q	NULL
E	NULL
3	NULL
o	NULL
8	NULL
71	NULL
=	NULL
o	NULL
©	NULL
®	NULL
7	NULL
o	NULL
o	NULL
§1	NULL
2	NULL
o	NULL
ss	NULL
g	NULL
--	NULL
-	NULL
~-	NULL
-s	NULL
~7	NULL
10	NULL
10	NULL
10	NULL
10	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
THROMBIN	NULL
ACTIVATES	NULL
NF-	NULL
«	NULL
kBp65	NULL
AND	NULL
ICAM-1	NULL
EXPRESSION	NULL
Thrombin	NULL
(	NULL
6	NULL
h	NULL
)	NULL
Control	NULL
Cell	NULL
Counts	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
80	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
Thrombin	NULL
(	NULL
24	NULL
h	NULL
)	NULL
Control	NULL
Cell	NULL
Counts	NULL
L	NULL
1	NULL
Luu	NULL
i	NULL
i	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
80	NULL
lau	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
FIGURE	NULL
2	NULL
.	NULL

Thrombin	NULL
induces	NULL
ICAM-1	NULL
expression	NULL
on	NULL
endothelial	NULL
cell	NULL
surface	NULL
.	NULL

Confluent	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
stimulated	NULL
with	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
!	NULL
)	NULL

for	NULL
3	NULL
,	NULL
6	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
with	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
!	NULL
)	NULL

or	NULL
for	NULL
12	NULL
h	NULL
with	NULL
TNF-a	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

ICAM-1	NULL
expression	NULL
was	NULL
quantitated	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
mAb	NULL
against	NULL
ICAM-1	NULL
(	NULL
BIRRO0O1	NULL
)	NULL
or	NULL
mAb	NULL
against	NULL
IgG	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Comparative	NULL
FACS	NULL
profiles	NULL
of	NULL
control	NULL
untreated	NULL
(	NULL
thick	NULL
line	NULL
)	NULL
,	NULL
thrombin-	NULL
,	NULL
or	NULL
TNF-	NULL
«	NULL
-treated	NULL
(	NULL
dotted	NULL
line	NULL
)	NULL
cells	NULL
are	NULL
shown	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
performed	NULL
is	NULL
shown	NULL
.	NULL

experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
polyclonal	NULL
rabbit	NULL
Ab	NULL
to	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
(	NULL
p65	NULL
[	NULL
RelA	NULL
]	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
)	NULL
(	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
pl	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
labeled	NULL
probe	NULL
for	NULL
another	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
in	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
in	NULL
low	NULL
ionic	NULL
strength	NULL
buffer	NULL
(	NULL
0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
for	NULL
the	NULL
gel	NULL
shift	NULL
analysis	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
ICAM-1	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
5'-AGCTTGGAAATTCCGGAGCTG-3	NULL
'	NULL
;	NULL
mut-ICAM-1	NULL
NF-KB	NULL
,	NULL
5-AGC	NULL
TTecAAATTCCGGAGCTG-3	NULL
'	NULL
.	NULL

The	NULL
oligonucleotide	NULL
designated	NULL
as	NULL
ICAM-1NF-	NULL
«	NULL
B	NULL
represents	NULL
a	NULL
21-bp	NULL
sequence	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
encompassing	NULL
the	NULL
downstream	NULL
NF-KB	NULL
binding	NULL
site	NULL
located	NULL
223	NULL
bp	NULL
upstream	NULL
of	NULL
translation	NULL
initiation	NULL
site	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
mut-ICAM-1NF-KB	NULL
is	NULL
the	NULL
same	NULL
as	NULL
ICAM-1NF-KB	NULL
,	NULL
except	NULL
that	NULL
it	NULL
has	NULL
2-bp	NULL
mutations	NULL
in	NULL
NF-KB	NULL
site	NULL
.	NULL

Sequence	NULL
motifs	NULL
within	NULL
the	NULL
oligonucleotides	NULL
are	NULL
underlined	NULL
and	NULL
the	NULL
mutations	NULL
are	NULL
shown	NULL
in	NULL
lower	NULL
case	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
Flow	NULL
cytometry	NULL
analysis	NULL
was	NULL
perfomed	NULL
as	NULL
described	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
HUVEC	NULL
monolayers	NULL
in	NULL
six-well	NULL
Primaria	NULL
tissue	NULL
culture	NULL
dishes	NULL
were	NULL
stimulated	NULL
with	NULL
thrombin	NULL
for	NULL
various	NULL
time	NULL
points	NULL
.	NULL

After	NULL
completion	NULL
of	NULL
incubation	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
removed	NULL
by	NULL
careful	NULL
trypsinization	NULL
,	NULL
and	NULL
washed	NULL
again	NULL
with	NULL
Ca	NULL
``	NULL
*/Mg**-free	NULL
PBS	NULL
before	NULL
incubating	NULL
with	NULL
20	NULL
%	NULL
horse	NULL
serum	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Following	NULL
two	NULL
washes	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
mouse	NULL
mAb	NULL
directed	NULL
against	NULL
human	NULL
ICAM-1	NULL
,	NULL
BIRROO0O1	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Robert	NULL
Rothlein	NULL
,	NULL
Boeringer	NULL
Ingleheim	NULL
,	NULL
Ridgefield	NULL
,	NULL
CT	NULL
)	NULL
(	NULL
43	NULL
)	NULL
,	NULL
in	NULL
Ca**/Mg**-free	NULL
PBS	NULL
containing	NULL
3	NULL
%	NULL
horse	NULL
serum	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
with	NULL
PBS/horse	NULL
serum	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
a	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
FITC-conjugated	NULL
secondary	NULL
Ab	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
fixed	NULL
with	NULL
2	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
in	NULL
a	NULL
FACScan	NULL
cytofluorometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
results	NULL
were	NULL
gated	NULL
for	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
above	NULL
the	NULL
fluorescence	NULL
produced	NULL
by	NULL
the	NULL
secondary	NULL
Ab	NULL
alone	NULL
.	NULL

PMN	NULL
adhesion	NULL
assay	NULL
PMN	NULL
adhesion	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
confluent	NULL
HUVEC	NULL
monolayers	NULL
in	NULL
24-well	NULL
plates	NULL
were	NULL
incubated	NULL
with	NULL
thrombin	NULL
for	NULL
2	NULL
or	NULL
6	NULL
h.	NULL
At	NULL
the	NULL
end	NULL
of	NULL
each	NULL
incubation	NULL
period	NULL
,	NULL
HUVEC	NULL
were	NULL
fixed	NULL
with	NULL
1	NULL
%	NULL
paraformaldehyde/PBS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
DMEM	NULL
without	NULL
serum	NULL
.	NULL

The	NULL
*'Cr-labeled	NULL
human	NULL
PMN	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
DMEM	NULL
)	NULL
were	NULL
distributed	NULL
at	NULL
1	NULL
ml/well	NULL
over	NULL
the	NULL
HUVEC	NULL
and	NULL
co-incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
and	NULL
98	NULL
%	NULL
humidity	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
contribution	NULL
of	NULL
ICAM-1	NULL
in	NULL
thrombin-induced	NULL
PMN	NULL
adherence	NULL
,	NULL
HUVEC	NULL
were	NULL
treated	NULL
with	NULL
RR1/1	NULL
(	NULL
mAb	NULL
to	NULL
ICAM-1	NULL
)	NULL
15	NULL
min	NULL
before	NULL
*'Cr-labeled	NULL
PMN	NULL
administration	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
.	NULL

HUVEC	NULL
monolayers	NULL
were	NULL
then	NULL
gently	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
DMEM	NULL
without	NULL
serum	NULL
to	NULL
remove	NULL
the	NULL
nonadherent	NULL
PMN	NULL
.	NULL

Endothelial	NULL
monolayers	NULL
were	NULL
kept	NULL
overnight	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
1	NULL
N	NULL
NaQOH	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
scraped	NULL
,	NULL
collected	NULL
in	NULL
polypropylene	NULL
tubes	NULL
,	NULL
and	NULL
counted	NULL
for	NULL
radioactivity	NULL
in	NULL
a	NULL
Tm	NULL
analytical	NULL
gamma	NULL
counter	NULL
.	NULL

Phase-contrast	NULL
microscopy	NULL
confirmed	NULL
HUVEC	NULL
integrity	NULL
and	NULL
PMN	NULL
adherence	NULL
to	NULL
HUVEC	NULL
.	NULL

Results	NULL
Thrombin	NULL
induces	NULL
ICAM-1	NULL
cell	NULL
surface	NULL
expression	NULL
and	NULL
PMN	NULL
adhesion	NULL
to	NULL
HUVEC	NULL
We	NULL
previously	NULL
showed	NULL
that	NULL
thrombin	NULL
increased	NULL
endothelial	NULL
adhesivity	NULL
toward	NULL
PMN	NULL
within	NULL
0.5	NULL
h	NULL
and	NULL
that	NULL
this	NULL
response	NULL
was	NULL
associated	NULL
with	NULL
type	NULL
I	NULL
activation	NULL
of	NULL
ICAM-1	NULL
expression	NULL
,	NULL
that	NULL
is	NULL
,	NULL
this	NULL
early	NULL
response	NULL
was	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
insensitive	NULL
and	NULL
did	NULL
not	NULL
require	NULL
increased	NULL
ICAM-1	NULL
mRNA	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
50	NULL
40	NULL
G	NULL
l=	NULL
]	NULL
1	NULL
PMN	NULL
Adherence	NULL
(	NULL
%	NULL
)	NULL
bo	NULL
l=	NULL
]	NULL
1	NULL
10	NULL
7	NULL
FIGURE	NULL
3	NULL
.	NULL

Thrombin	NULL
induces	NULL
endothelial	NULL
adhesivity	NULL
toward	NULL
PMN	NULL
.	NULL

Confluent	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
CHX	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
for	NULL
2	NULL
or	NULL
6	NULL
h	NULL
,	NULL
washed	NULL
with	NULL
DMEM	NULL
,	NULL
and	NULL
fixed	NULL
with	NULL
1	NULL
%	NULL
paraformaldehyde/PBS	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
after	NULL
which	NULL
unstimulated	NULL
``	NULL
Cr-labeled	NULL
PMN	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
layered	NULL
onto	NULL
endothelial	NULL
monolayers	NULL
for	NULL
1	NULL
h	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
DMEM	NULL
with	NULL
HEPES	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
adhesion	NULL
was	NULL
determined	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
thrombin-stimulated	NULL
HUVEC	NULL
were	NULL
preincubated	NULL
with	NULL
mAb	NULL
RR1/1	NULL
(	NULL
anti-ICAM-1	NULL
)	NULL
(	NULL
10	NULL
g/m	NULL
!	NULL
)	NULL

before	NULL
applying	NULL
PMN	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
1	NULL
SE	NULL
;	NULL
»	NULL
=	NULL
6	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

expression	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
thrombin-induced	NULL
ICAM-1	NULL
expression	NULL
is	NULL
initially	NULL
independent	NULL
of	NULL
de	NULL
novo	NULL
ICAM-1	NULL
protein	NULL
synthesis	NULL
,	NULL
but	NULL
later	NULL
becomes	NULL
protein	NULL
synthesis	NULL
dependent	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
time	NULL
course	NULL
of	NULL
thrombin-induced	NULL
ICAM-1	NULL
expression	NULL
on	NULL
endothelial	NULL
cell	NULL
surface	NULL
as	NULL
assessed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

ICAM-1	NULL
expression	NULL
increased	NULL
within	NULL
6	NULL
h	NULL
of	NULL
thrombin	NULL
challenge	NULL
and	NULL
continued	NULL
to	NULL
increase	NULL
further	NULL
at	NULL
12	NULL
and	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

TNF-	NULL
@	NULL
,	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
also	NULL
induced	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
ICAM-1	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
time	NULL
course	NULL
of	NULL
PMN	NULL
adherence	NULL
to	NULL
HUVEC	NULL
induced	NULL
by	NULL
thrombin	NULL
challenge	NULL
correlated	NULL
with	NULL
the	NULL
kinetics	NULL
of	NULL
ICAM-1	NULL
cell	NULL
surface	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Approximately	NULL
50	NULL
%	NULL
of	NULL
the	NULL
increased	NULL
PMN	NULL
adherence	NULL
to	NULL
HUVEC	NULL
at	NULL
6	NULL
h	NULL
was	NULL
CHX	NULL
sensitive	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
50	NULL
%	NULL
of	NULL
ICAM-1	NULL
expression	NULL
at	NULL
6	NULL
h	NULL
was	NULL
CHX	NULL
sensitive	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
CHX	NULL
sensitivity	NULL
of	NULL
PMN	NULL
adhesion	NULL
in	NULL
the	NULL
6-h	NULL
thrombin-stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
was	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
thrombin	NULL
response	NULL
at	NULL
2	NULL
h	NULL
,	NULL
which	NULL
was	NULL
insensitive	NULL
to	NULL
CHX	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
that	NULL
pretreatment	NULL
of	NULL
HUVEC	NULL
with	NULL
mAb	NULL
RR1/1	NULL
reduced	NULL
PMN	NULL
adherence	NULL
at	NULL
6	NULL
h	NULL
by	NULL
~80	NULL
%	NULL
,	NULL
indicating	NULL
a	NULL
role	NULL
of	NULL
ICAM-1	NULL
in	NULL
mediating	NULL
thrombin-induced	NULL
PMN	NULL
adhesion	NULL
.	NULL

Given	NULL
that	NULL
type	NULL
I	NULL
activation	NULL
of	NULL
P-selectin	NULL
and	NULL
P-selectin-medi-ated	NULL
PMN	NULL
adherence	NULL
is	NULL
rapid	NULL
and	NULL
returns	NULL
to	NULL
the	NULL
basal	NULL
level	NULL
within	NULL
2	NULL
h	NULL
after	NULL
thrombin	NULL
challenge	NULL
of	NULL
HUVEC	NULL
(	NULL
9	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
type	NULL
I	NULL
activation	NULL
of	NULL
P-selectin	NULL
contributes	NULL
to	NULL
6-h	NULL
thrombin-induced	NULL
PMN	NULL
adherence	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
studies	NULL
have	NULL
shown	NULL
type	NULL
II	NULL
activation	NULL
of	NULL
P-selectin	NULL
gene	NULL
in	NULL
murine	NULL
,	NULL
but	NULL
not	NULL
in	NULL
human	NULL
,	NULL
endothelial	NULL
cells	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
thrombin	NULL
mediates	NULL
type	NULL
II	NULL
activation	NULL
of	NULL
P-selectin	NULL
expression	NULL
,	NULL
and	NULL
therefore	NULL
contributes	NULL
to	NULL
6-h	NULL
thrombin-induced	NULL
PMN	NULL
adherence	NULL
to	NULL
HUVEC	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
an	NULL
early	NULL
protein	NULL
synthesis-independent	NULL
ICAM-1	NULL
expression	NULL
induced	NULL
by	NULL
thrombin	NULL
and	NULL
a	NULL
delayed	NULL
and	NULL
progressive	NULL
protein	NULL
synthesis-dependent	NULL
response	NULL
,	NULL
which	NULL
prolongs	NULL
and	NULL
stabilizes	NULL
PMN	NULL
adhesion	NULL
.	NULL

5469	NULL
A	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
0	NULL
0.5	NULL
2	NULL
4	NULL
8	NULL
24	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
4+	NULL
o-	NULL
#	NULL
-	NULL
+o	NULL
o	NULL
}	NULL
+	NULL
Coe	NULL
caron	NULL
»	NULL
a.	NULL
a	NULL
ICAM-1	NULL
3.3	NULL
kb	NULL
»	NULL
B	NULL
1.75	NULL
1.50	NULL
C1	NULL
Control	NULL
IBM	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
1.25	NULL
1.00	NULL
ICAM-1	NULL
(	NULL
3.3	NULL
kb	NULL
)	NULL
/GAPDH	NULL
0.257	NULL
gooll-Time	NULL
(	NULL
h	NULL
)	NULL
FIGURE	NULL
4	NULL
.	NULL

Thrombin	NULL
induces	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
in	NULL
HUVEC	NULL
.	NULL

Confluent	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
stimulated	NULL
with	NULL
or	NULL
without	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
hybridizations	NULL
with	NULL
human	NULL
ICAM-1	NULL
or	NULL
rat	NULL
GAPDH	NULL
cDNAs	NULL
,	NULL
which	NULL
hybridize	NULL
to	NULL
a	NULL
3.3-	NULL
or	NULL
1.3-kb	NULL
transcript	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
,	NULL
Autoradiogram	NULL
.	NULL

B	NULL
,	NULL
Bar	NULL
graph	NULL
representing	NULL
the	NULL
relative	NULL
intensities	NULL
of	NULL
ICAM-1	NULL
mRNA	NULL
signals	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
performed	NULL
is	NULL
shown	NULL
.	NULL

Thrombin	NULL
induces	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
To	NULL
determine	NULL
whether	NULL
protein	NULL
synthesis-dependent	NULL
expression	NULL
of	NULL
ICAM-1	NULL
is	NULL
preceded	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
measure	NULL
the	NULL
abundance	NULL
of	NULL
ICAM-1	NULL
transcript	NULL
,	NULL
up	NULL
to	NULL
24	NULL
h	NULL
,	NULL
after	NULL
addition	NULL
of	NULL
thrombin	NULL
(	NULL
2.5	NULL
to	NULL
the	NULL
medium	NULL
.	NULL

Thrombin	NULL
induced	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
in	NULL
a	NULL
time-dependent	NULL
manner	NULL
,	NULL
with	NULL
maximum	NULL
induction	NULL
occurring	NULL
between	NULL
2	NULL
and	NULL
4	NULL
h	NULL
after	NULL
thrombin	NULL
challenge	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
~55	NULL
%	NULL
decrease	NULL
at	NULL
8	NULL
h	NULL
,	NULL
and	NULL
returned	NULL
to	NULL
the	NULL
basal	NULL
level	NULL
by	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Thrombin-induced	NULL
ICAM-1	NULL
gene	NULL
transcription	NULL
requires	NULL
activation	NULL
of	NULL
PAR-1	NULL
We	NULL
evaluated	NULL
the	NULL
effects	NULL
of	NULL
TRAP	NULL
,	NULL
a	NULL
14-amino-acid	NULL
peptide	NULL
representing	NULL
the	NULL
new	NULL
NH	NULL
,	NULL
terminus	NULL
of	NULL
PAR-1	NULL
generated	NULL
after	NULL
thrombin	NULL
cleavage	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
requires	NULL
activation	NULL
of	NULL
PAR-1	NULL
.	NULL

Both	NULL
thrombin	NULL
and	NULL
TRAP	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
ICAM-1	NULL
transcript	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
3.3-kb	NULL
transcript	NULL
increased	NULL
slightly	NULL
with	NULL
1	NULL
U/ml	NULL
thrombin	NULL
or	NULL
12.5	NULL
wM	NULL
TRAP	NULL
;	NULL
the	NULL
maximum	NULL
induction	NULL
occurred	NULL
with	NULL
5	NULL
U/ml	NULL
or	NULL
50	NULL
uM	NULL
TRAP	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
thrombin-induced	NULL
ICAM-1	NULL
transcription	NULL
occurs	NULL
secondary	NULL
to	NULL
the	NULL
cleavage	NULL
of	NULL
PAR-1	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5470	NULL
ICAM-1	NULL
3.3	NULL
kb	NULL
»	NULL
GAPDH	NULL
»	NULL
'	NULL
‘	NULL
'	NULL
'	NULL
Thrombin	NULL
(	NULL
U/ml	NULL
)	NULL
=	NULL
1	NULL
2.5	NULL
5	NULL
a	NULL
1.504	NULL
1.251	NULL
T	NULL
I	NULL
.	NULL

&	NULL
1.00	NULL
,	NULL
3	NULL
a	NULL
0.751	NULL
g	NULL
0.50	NULL
}	NULL
|	NULL
[	NULL
]	NULL
0.257	NULL
|	NULL
0.00-	NULL
-	NULL
Thrombin	NULL
(	NULL
U/ml	NULL
!	NULL
)	NULL

-	NULL
1	NULL
2.5	NULL
5	NULL
'	NULL
'	NULL
ICAM-1	NULL
3.3	NULL
kb	NULL
-	NULL
»	NULL
THROMBIN	NULL
ACTIVATES	NULL
NF-	NULL
«	NULL
kBp65	NULL
AND	NULL
ICAM-1	NULL
EXPRESSION	NULL
B	NULL
-	NULL
``	NULL
GAPDH	NULL
»	NULL
'	NULL
'	NULL
'	NULL
``	NULL
TRAP	NULL
(	NULL
uM	NULL
)	NULL
-	NULL
12.5	NULL
25	NULL
50	NULL
100	NULL
b	NULL
0.8	NULL
x	NULL
0.6	NULL
&	NULL
$	NULL
a	NULL
04	NULL
3	NULL
6	NULL
02	NULL
]	NULL
00	NULL
4	NULL
``	NULL
s	NULL
J	NULL
TRAP	NULL
(	NULL
uM	NULL
)	NULL
_	NULL
-	NULL
_	NULL
12.5	NULL
25	NULL
50	NULL
100	NULL
FIGURE	NULL
5	NULL
.	NULL

Thrombin-induced	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
requires	NULL
activation	NULL
of	NULL
cell	NULL
surface	NULL
PAR-1	NULL
.	NULL

HUVEC	NULL
were	NULL
treated	NULL
for	NULL
3	NULL
h	NULL
with	NULL
thrombin	NULL
(	NULL
A	NULL
)	NULL
or	NULL
TRAP	NULL
(	NULL
B	NULL
)	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
.	NULL

ICAM-1	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
expression	NULL
was	NULL
determined	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
Autoradiograms	NULL
.	NULL

a	NULL
and	NULL
b	NULL
,	NULL
Bar	NULL
graphs	NULL
representing	NULL
the	NULL
relative	NULL
intensities	NULL
of	NULL
ICAM-1	NULL
mRNA	NULL
signals	NULL
in	NULL
response	NULL
to	NULL
thrombin	NULL
and	NULL
TRAP	NULL
,	NULL
respectively	NULL
(	NULL
representative	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
)	NULL
.	NULL

Thrombin-induced	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
does	NULL
not	NULL
require	NULL
novel	NULL
protein	NULL
synthesis	NULL
We	NULL
used	NULL
CHX	NULL
to	NULL
determine	NULL
whether	NULL
thrombin	NULL
induction	NULL
of	NULL
ICAM-1	NULL
transcript	NULL
was	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
thrombin	NULL
treatment	NULL
or	NULL
it	NULL
required	NULL
the	NULL
synthesis	NULL
of	NULL
additional	NULL
proteins	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
CHX	NULL
in	NULL
the	NULL
medium	NULL
during	NULL
thrombin	NULL
treatment	NULL
of	NULL
HUVEC	NULL
did	NULL
not	NULL
prevent	NULL
the	NULL
thrombin-induced	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
proteins	NULL
necessary	NULL
to	NULL
mediate	NULL
thrombin	NULL
response	NULL
were	NULL
already	NULL
present	NULL
in	NULL
cells	NULL
.	NULL

CHX	NULL
alone	NULL
caused	NULL
a	NULL
slight	NULL
induction	NULL
of	NULL
ICAM-1	NULL
transcript	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
a	NULL
characteristic	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
genes	NULL
,	NULL
since	NULL
CHX	NULL
is	NULL
known	NULL
to	NULL
activate	NULL
nuclear	NULL
transport	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
presumably	NULL
by	NULL
inhibiting	NULL
synthesis	NULL
of	NULL
relatively	NULL
labile	NULL
IB	NULL
proteins	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
prevents	NULL
thrombin-induced	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
To	NULL
further	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
NF-B	NULL
in	NULL
mediating	NULL
ICAM-1	NULL
expression	NULL
by	NULL
thrombin	NULL
,	NULL
we	NULL
used	NULL
PDTC	NULL
,	NULL
an	NULL
antioxidant	NULL
that	NULL
prevents	NULL
NF-KB	NULL
activation	NULL
,	NULL
and	NULL
thereby	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
through	NULL
its	NULL
ability	NULL
to	NULL
chelate	NULL
metal	NULL
ions	NULL
and	NULL
deliver	NULL
thiol	NULL
groups	NULL
to	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Confluent	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
treated	NULL
with	NULL
PDTC	NULL
for	NULL
0.5	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
thrombin	NULL
for	NULL
3	NULL
h.	NULL
PDTC	NULL
pre-	NULL
vented	NULL
thrombin-induced	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
reactive	NULL
oxygen	NULL
species	NULL
,	NULL
produced	NULL
during	NULL
inflammatory	NULL
response	NULL
,	NULL
function	NULL
as	NULL
second	NULL
messengers	NULL
in	NULL
activating	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
may	NULL
mediate	NULL
ICAM-1	NULL
transcription	NULL
in	NULL
thrombin-stimulated	NULL
endothelial	NULL
cells	NULL
.	NULL

Thrombin	NULL
activates	NULL
ICAM-1	NULL
gene	NULL
promoter	NULL
in	NULL
endothelial	NULL
cells	NULL
We	NULL
assessed	NULL
the	NULL
effects	NULL
of	NULL
thrombin	NULL
on	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
to	NULL
demonstrate	NULL
that	NULL
thrombin	NULL
was	NULL
capable	NULL
of	NULL
activating	NULL
ICAM-1	NULL
gene	NULL
transcription	NULL
.	NULL

HUVEC	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
full-length	NULL
wild-type	NULL
construct	NULL
containing	NULL
1393	NULL
bp	NULL
of	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
(	NULL
ICAM-1	NULL
LUC	NULL
)	NULL
.	NULL

Thrombin	NULL
increased	NULL
ICAM-1	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

84	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
but	NULL
more	NULL
pronounced	NULL
activation	NULL
by	NULL
thrombin	NULL
or	NULL
TRAP	NULL
was	NULL
observed	NULL
in	NULL
Eahy926	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

TNF-a	NULL
or	NULL
PMA	NULL
,	NULL
used	NULL
as	NULL
positive	NULL
controls	NULL
,	NULL
also	NULL
activated	NULL
the	NULL
promoter	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Since	NULL
transfection	NULL
efficiency	NULL
and	NULL
the	NULL
consequent	NULL
luciferase	NULL
activity	NULL
were	NULL
2-	NULL
to	NULL
3-fold	NULL
higher	NULL
in	NULL
Eahy926	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
these	NULL
cells	NULL
to	NULL
localize	NULL
the	NULL
thrombin-responsive	NULL
region	NULL
within	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
(	NULL
as	NULL
described	NULL
below	NULL
)	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
ICAM-1	NULL
3.3	NULL
kb	NULL
-	NULL
ame	NULL
GAPDH	NULL
»	NULL
-	NULL
``	NULL
Wie	NULL
'	NULL
.	NULL

CHX	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
_-	NULL
-	NULL
+	NULL
&	NULL
B	NULL
ICAM-1	NULL
(	NULL
3.3	NULL
CHX	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
__	NULL
-	NULL
+	NULL
_	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
!	NULL
)	NULL

___	NULL
-	NULL
t	NULL
+	NULL
FIGURE	NULL
6	NULL
.	NULL

Thrombin-induced	NULL
ICAM-1	NULL
gene	NULL
transcription	NULL
does	NULL
not	NULL
require	NULL
novel	NULL
protein	NULL
synthesis	NULL
.	NULL

Confluent	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
pretreated	NULL
for	NULL
0.5	NULL
h	NULL
with	NULL
CHX	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
thrombin	NULL
for	NULL
a	NULL
period	NULL
of	NULL
3	NULL
h	NULL
in	NULL
continuous	NULL
presence	NULL
of	NULL
CHX	NULL
.	NULL

ICAM-1	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
Northern	NULL
blotting	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
,	NULL
autoradiogram	NULL
;	NULL
B	NULL
,	NULL
bar	NULL
graph	NULL
representing	NULL
the	NULL
relative	NULL
intensities	NULL
of	NULL
ICAM-1	NULL
mRNA	NULL
signals	NULL
(	NULL
representative	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
)	NULL
.	NULL

Localization	NULL
of	NULL
thrombin-responsive	NULL
region	NULL
within	NULL
ICAM-1	NULL
promoter	NULL
The	NULL
ICAM-1	NULL
promoter	NULL
contains	NULL
a	NULL
number	NULL
of	NULL
cis-acting	NULL
elements	NULL
of	NULL
potential	NULL
importance	NULL
in	NULL
mediating	NULL
the	NULL
activation	NULL
of	NULL
ICAM-1	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
used	NULL
a	NULL
set	NULL
of	NULL
5	NULL
'	NULL
deletion	NULL
mutation	NULL
constructs	NULL
containing	NULL
different	NULL
lengths	NULL
of	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
to	NULL
localize	NULL
the	NULL
thrombin-responsive	NULL
ele-ments	NULL
.	NULL

Deletion	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
sequences	NULL
393	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
ATG	NULL
start	NULL
codon	NULL
decreased	NULL
basal	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

AP-1	NULL
,	NULL
AP-1/Ets	NULL
repeats	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
AP-3	NULL
are	NULL
the	NULL
apparent	NULL
elements	NULL
in	NULL
this	NULL
region	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
sites	NULL
are	NULL
important	NULL
for	NULL
basal	NULL
expression	NULL
of	NULL
construct	NULL
393	NULL
ICAM-1	NULL
LUC	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
construct	NULL
was	NULL
still	NULL
strongly	NULL
activated	NULL
by	NULL
thrombin	NULL
and	NULL
TRAP	NULL
,	NULL
indicating	NULL
that	NULL
AP-1	NULL
,	NULL
AP-1/Ets	NULL
,	NULL
AP-3	NULL
,	NULL
and	NULL
the	NULL
upstream	NULL
NF-B	NULL
site	NULL
(	NULL
533	NULL
bp	NULL
upstream	NULL
of	NULL
translation	NULL
start	NULL
site	NULL
)	NULL
are	NULL
not	NULL
essential	NULL
for	NULL
thrombin	NULL
responsiveness	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Thrombin	NULL
responsiveness	NULL
was	NULL
lost	NULL
upon	NULL
deletion	NULL
from	NULL
position	NULL
393	NULL
to	NULL
176	NULL
bp	NULL
,	NULL
suggesting	NULL
that	NULL
cis-regulatory	NULL
elements	NULL
responsible	NULL
for	NULL
thrombin	NULL
response	NULL
reside	NULL
within	NULL
this	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Potential	NULL
binding	NULL
sites	NULL
5471	NULL
A	NULL
ICAM-1	NULL
3.3	NULL
kb	NULL
®-	NULL
a-	NULL
Yo	NULL
a	NULL
h	NULL
:	NULL
>	NULL
tBQ0	NULL
0	NULL
q	NULL
0	NULL
#	NULL
PDTC	NULL
(	NULL
uM	NULL
)	NULL
-	NULL
10	NULL
50	NULL
100	NULL
-	NULL
10	NULL
50	NULL
100	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
-o	NULL
-	NULL
-	NULL
#	NULL
+o	NULL
+	NULL
+o	NULL
+	NULL
B	NULL
1.25	NULL
,	NULL
1.004	NULL
0.757	NULL
ICAM-1	NULL
(	NULL
3.3	NULL
kb	NULL
)	NULL
/GAPDH	NULL
0.50	NULL
0.00	NULL
PDTC	NULL
(	NULL
uM	NULL
)	NULL
-	NULL
10	NULL
50	NULL
100	NULL
-	NULL
10	NULL
50	NULL
100	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/mi	NULL
)	NULL
y	NULL
-	NULL
-	NULL
=-	NULL
>	NULL
-	NULL
>	NULL
+	NULL
0	NULL
4	NULL
0	NULL
4+	NULL
O+	NULL
FIGURE	NULL
7	NULL
.	NULL

PDTC	NULL
prevents	NULL
thrombin-induced	NULL
ICAM-1	NULL
gene	NULL
transcription	NULL
.	NULL

Confluent	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
PDTC	NULL
for	NULL
0.5	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
for	NULL
3	NULL
h	NULL
in	NULL
continuous	NULL
presence	NULL
of	NULL
PDTC	NULL
.	NULL

ICAM-1	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
expression	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
,	NULL
Autoradiogram	NULL
;	NULL
B	NULL
,	NULL
bar	NULL
graph	NULL
representing	NULL
the	NULL
relative	NULL
intensities	NULL
of	NULL
ICAM-1	NULL
mRNA	NULL
signals	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
performed	NULL
is	NULL
shown	NULL
.	NULL

for	NULL
AP-1	NULL
(	NULL
tetradecanoylphorbol-13-acetate	NULL
responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
)	NULL
,	NULL
SP1	NULL
,	NULL
C/EBP	NULL
,	NULL
and	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
are	NULL
located	NULL
within	NULL
this	NULL
region	NULL
.	NULL

Since	NULL
thrombin	NULL
is	NULL
known	NULL
to	NULL
stimulate	NULL
AP-1	NULL
DNA	NULL
binding	NULL
and	NULL
AP-1-mediated	NULL
transactivation	NULL
(	NULL
47	NULL
)	NULL
,	NULL
we	NULL
used	NULL
a	NULL
plasmid	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
TRE	NULL
from	NULL
ICAM-1	NULL
gene	NULL
linked	NULL
to	NULL
a	NULL
minimal	NULL
B-glo-bin	NULL
promoter-luciferase	NULL
reporter	NULL
gene	NULL
to	NULL
determine	NULL
whether	NULL
TRE	NULL
could	NULL
function	NULL
as	NULL
the	NULL
thrombin	NULL
response	NULL
element	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
,	NULL
TRE-directed	NULL
promoter	NULL
activity	NULL
did	NULL
not	NULL
increase	NULL
significantly	NULL
when	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
thrombin	NULL
or	NULL
TRAP	NULL
.	NULL

Mutation	NULL
of	NULL
downstream	NULL
NF-KB	NULL
site	NULL
prevents	NULL
thrombin-induced	NULL
ICAM-1	NULL
promoter	NULL
activation	NULL
To	NULL
ascertain	NULL
the	NULL
role	NULL
of	NULL
Sp-1	NULL
,	NULL
C/EBP	NULL
,	NULL
and	NULL
downstream	NULL
NF-KB	NULL
sites	NULL
in	NULL
mediating	NULL
ICAM-1	NULL
promoter	NULL
activation	NULL
by	NULL
thrombin	NULL
,	NULL
we	NULL
transfected	NULL
HUVEC	NULL
with	NULL
pGL2-WT	NULL
and	NULL
-MU	NULL
vectors	NULL
containing	NULL
wild-type	NULL
and	NULL
mutant	NULL
versions	NULL
of	NULL
Sp-1	NULL
(	NULL
pGL2-Sp-1-MU	NULL
)	NULL
,	NULL
C/EBP	NULL
(	NULL
pGL2-C/EBP-MU	NULL
)	NULL
,	NULL
and	NULL
downstream	NULL
NF-KB	NULL
(	NULL
pGL2-NF-	NULL
«	NULL
B-MU	NULL
)	NULL
site	NULL
.	NULL

Thrombin	NULL
induced	NULL
a	NULL
~4-fold	NULL
increase	NULL
in	NULL
ICAM-1	NULL
promoter	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5472	NULL
FIGURE	NULL
8	NULL
.	NULL

Activation	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
by	NULL
thrombin	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
1393-bp	NULL
(	NULL
A	NULL
)	NULL
HUVEC	NULL
ICAM-1LUC	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
-_	NULL
.	NULL

300	NULL
HUVEC	NULL
(	NULL
4	NULL
)	NULL
or	NULL
Eahy926	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
using	NULL
lipo-	NULL
Fz	NULL
g	NULL
250	NULL
fectamine	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Meth-	NULL
g	NULL
§	NULL
ods	NULL
.	NULL

At	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
left	NULL
<	NULL
2	NULL
``	NULL
200	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
thrombin	NULL
,	NULL
§	NULL
8	NULL
150	NULL
TRAP	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
PMA	NULL
at	NULL
the	NULL
indicated	NULL
concen-	NULL
.	NULL

$	NULL
2	NULL
ibo	NULL
trations	NULL
,	NULL
and	NULL
were	NULL
harvested	NULL
15	NULL
h	NULL
after	NULL
treatment	NULL
,	NULL
g	NULL
é	NULL
so	NULL
and	NULL
cell	NULL
extract	NULL
was	NULL
assessed	NULL
for	NULL
luciferase	NULL
activ-	NULL
-	NULL
v	NULL
ity	NULL
using	NULL
a	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
.	NULL

Lucif-	NULL
0	NULL
erase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
RLU/pug	NULL
of	NULL
cell	NULL
pro	NULL
tein	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
performed	NULL
in	NULL
triplicates	NULL
.	NULL

activity	NULL
when	NULL
pGL2-WT	NULL
was	NULL
used	NULL
,	NULL
whereas	NULL
thrombin	NULL
failed	NULL
to	NULL
increase	NULL
ICAM-1	NULL
promoter	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
pGL2-NF-	NULL
«	NULL
B-MU	NULL
,	NULL
which	NULL
is	NULL
the	NULL
same	NULL
as	NULL
pGL2-NF-	NULL
«	NULL
B-WT	NULL
,	NULL
except	NULL
that	NULL
it	NULL
has	NULL
2-bp	NULL
mutations	NULL
in	NULL
downstream	NULL
NF-KB	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Sp-1	NULL
and	NULL
C/EBP	NULL
sites	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
important	NULL
,	NULL
as	NULL
the	NULL
mutations	NULL
in	NULL
these	NULL
sites	NULL
failed	NULL
to	NULL
prevent	NULL
thrombin-induced	NULL
luciferase	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
pGL2-Sp-1-MU	NULL
and	NULL
pGL2-C/	NULL
EBP-MU	NULL
vectors	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
is	NULL
critical	NULL
in	NULL
mediating	NULL
thrombin-induced	NULL
activation	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
.	NULL

NF-KB	NULL
activation	NULL
is	NULL
essential	NULL
to	NULL
mediate	NULL
thrombin	NULL
response	NULL
To	NULL
determine	NULL
whether	NULL
activation	NULL
of	NULL
NF-KB	NULL
site	NULL
is	NULL
necessary	NULL
to	NULL
confer	NULL
thrombin	NULL
inducibility	NULL
of	NULL
ICAM-1	NULL
gene	NULL
,	NULL
we	NULL
transfected	NULL
HUVEC	NULL
with	NULL
a	NULL
plasmid	NULL
pNF-	NULL
«	NULL
BLUC	NULL
containing	NULL
five	NULL
copies	NULL
of	NULL
consensus	NULL
NF-kB	NULL
sequence	NULL
from	NULL
Ig	NULL
gene	NULL
linked	NULL
to	NULL
a	NULL
minimal	NULL
adenovirus	NULL
E1B	NULL
promoter-luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

11	NULL
,	NULL
NE-	NULL
«	NULL
B-directed	NULL
promoter	NULL
activity	NULL
increased	NULL
~3-fold	NULL
when	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
thrombin	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
NF-KB	NULL
sequence	NULL
alone	NULL
is	NULL
capable	NULL
of	NULL
mediating	NULL
thrombin	NULL
response	NULL
.	NULL

Thrombin	NULL
induces	NULL
DNA-binding	NULL
activity	NULL
on	NULL
downstream	NULL
NF-KB	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
thrombin-activated	NULL
DNA-binding	NULL
pro	NULL
8	NULL
3	NULL
arves	NULL
-	NULL
F	NULL
ars	NULL
meson	NULL
c	NULL
Bes	NULL
1393	NULL
_	NULL
K~-_	NULL
I	NULL
T	NULL
T	NULL
T	NULL
TT	NULL
LI	NULL
L	NULL
JT	NULL
nc	NULL
}	NULL
1290	NULL
_	NULL
-940-865	NULL
-533	NULL
-410	NULL
-321-243-237-223	NULL
-84	NULL
-981	NULL
-176	NULL
J	NULL
|	NULL
ag	NULL
LUC	NULL
__|	NULL
AG	NULL
:	NULL
-393	NULL
_	NULL
K	NULL
IX	NULL
T	NULL
L	NULL
TIT	NULL
T6	NULL
:	NULL
we	NULL
_	NULL
]	NULL
THROMBIN	NULL
ACTIVATES	NULL
NF-	NULL
«	NULL
kBp65	NULL
AND	NULL
ICAM-1	NULL
EXPRESSION	NULL
(	NULL
B	NULL
)	NULL
Eahy926	NULL
&	NULL
700	NULL
2	NULL
©	NULL
soo	NULL
3	NULL
§	NULL
3	NULL
a	NULL
.	NULL

500	NULL
i	NULL
é	NULL
400	NULL
g	NULL
9	NULL
300	NULL
55	NULL
5	NULL
200	NULL
3	NULL
g	NULL
100	NULL
~~	NULL
o	NULL
7	NULL
C	NULL
7	NULL
n	NULL
ro	NULL
Ne	NULL
n	NULL
``	NULL
ro	NULL
,	NULL
Ne	NULL
,	NULL
``	NULL
A	NULL
``	NULL
3	NULL
,	NULL
``	NULL
4	NULL
,	NULL
(	NULL
Too	NULL
``	NULL
tv	NULL
``	NULL
a	NULL
,	NULL
Qf	NULL
’	NULL
Ooze	NULL
‘	NULL
ffjpﬁo	NULL
,	NULL
,	NULL
Re	NULL
,	NULL
G4	NULL
6	NULL
Sasy	NULL
Pay	NULL
Ag	NULL
&	NULL
ry	NULL
ry	NULL
``	NULL
my	NULL
``	NULL
oy	NULL
By	NULL
``	NULL
4°	NULL
``	NULL
*	NULL
``	NULL
teins	NULL
,	NULL
we	NULL
synthesized	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
this	NULL
sequence	NULL
,	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
from	NULL
thrombin-stimulated	NULL
HUVEC	NULL
,	NULL
and	NULL
determined	NULL
the	NULL
binding	NULL
activity	NULL
by	NULL
EMSA	NULL
.	NULL

Fig	NULL
.	NULL

12	NULL
shows	NULL
that	NULL
thrombin-induced	NULL
DNA-binding	NULL
activities	NULL
,	NULL
when	NULL
assayed	NULL
on	NULL
non-denaturing	NULL
gel	NULL
electrophoresis	NULL
,	NULL
resolved	NULL
into	NULL
three	NULL
closely	NULL
migrating	NULL
bands	NULL
.	NULL

We	NULL
performed	NULL
competition	NULL
experiments	NULL
to	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
these	NULL
binding	NULL
activities	NULL
.	NULL

These	NULL
DNA-binding	NULL
activities	NULL
were	NULL
competed	NULL
by	NULL
specific	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
ICAM-1NF-	NULL
«	NULL
B	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
yet	NULL
remained	NULL
intact	NULL
when	NULL
challenged	NULL
with	NULL
an	NULL
oligonucleotide	NULL
(	NULL
mut-ICAM-1NF-	NULL
«	NULL
B	NULL
)	NULL
bearing	NULL
2-bp	NULL
substitution	NULL
in	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
(	NULL
Jane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
fast	NULL
migrating	NULL
activities	NULL
(	NULL
bands	NULL
2	NULL
and	NULL
3	NULL
)	NULL
are	NULL
nonspecific	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
these	NULL
bands	NULL
when	NULL
the	NULL
same	NULL
nuclear	NULL
extract	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
mutant	NULL
version	NULL
of	NULL
downstream	NULL
NF-KB	NULL
site	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

We	NULL
next	NULL
performed	NULL
supershift	NULL
experiments	NULL
using	NULL
specific	NULL
Abs	NULL
to	NULL
p50	NULL
,	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
,	NULL
p52	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
to	NULL
determine	NULL
the	NULL
identity	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
thrombin-induced	NULL
NF-	NULL
«	NULL
B-binding	NULL
complex	NULL
.	NULL

Incubation	NULL
with	NULL
Ab	NULL
to	NULL
p65	NULL
abolished	NULL
the	NULL
slowest	NULL
migrating	NULL
complex	NULL
(	NULL
band	NULL
1	NULL
)	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
supershift	NULL
,	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
fast	NULL
migrating	NULL
protein	NULL
:	NULL
DNA	NULL
complexes	NULL
(	NULL
bands	NULL
2	NULL
and	NULL
3	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

134	NULL
)	NULL
.	NULL

Abs	NULL
to	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
c-Rel	NULL
,	NULL
or	NULL
Rel	NULL
B	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
any	NULL
of	NULL
these	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

13A	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
we	NULL
used	NULL
TNF-a	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
Bp65	NULL
binding	NULL
to	NULL
the	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
(	NULL
23	NULL
)	NULL
.	NULL

As	NULL
in	NULL
the	NULL
case	NULL
of	NULL
thrombin	NULL
,	NULL
Ab	NULL
to	NULL
p65	NULL
also	NULL
[	NULL
-T	NULL
]	NULL
Control	NULL
{	NULL
S	NULL
Thrombin	NULL
22	NULL
TRAP	NULL
400	NULL
350	NULL
-	NULL
”	NULL
y	NULL
4	NULL
soo	NULL
-	NULL
Z	NULL
3	NULL
(	NULL
te	NULL
2	NULL
A	NULL
z	NULL
5	NULL
w	NULL
Psy	NULL
3	NULL
|	NULL
[	NULL
1	NULL
©	NULL
200	NULL
-	NULL
A	NULL
.	NULL

o	NULL
U	NULL
L_	NULL
$	NULL
|	NULL
|	NULL
3	NULL
150	NULL
-	NULL
A	NULL
A	NULL
3	NULL
a	NULL
1	NULL
.	NULL

3	NULL
[	NULL
1	NULL
.	NULL

100	NULL
-	NULL
{	NULL
_	NULL
z	NULL
(	NULL
L_	NULL
U	NULL
A_	NULL
A	NULL
A	NULL
.	NULL

#	NULL
A	NULL
D	NULL
&	NULL
``	NULL
%	NULL
*	NULL
%	NULL
$	NULL
0147	NULL
4	NULL
4	NULL
)	NULL
%	NULL
o	NULL
.	NULL

YZ	NULL
Z	NULL
/	NULL
Z	NULL
<	NULL
T	NULL
C	NULL
(	NULL
00	NULL
Gb	NULL
O	NULL
``	NULL
%	NULL
C	NULL
FIGURE	NULL
9	NULL
.	NULL

Localization	NULL
of	NULL
thrombin-responsive	NULL
region	NULL
within	NULL
ICAM-1	NULL
promoter	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
different	NULL
ICAM-1LUC	NULL
constructs	NULL
is	NULL
shown	NULL
at	NULL
Teff	NULL
.	NULL

The	NULL
nucleotide	NULL
position	NULL
of	NULL
5	NULL
``	NULL
end	NULL
of	NULL
each	NULL
construct	NULL
is	NULL
given	NULL
relative	NULL
to	NULL
initiation	NULL
codon	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
relative	NULL
luciferase	NULL
activities	NULL
per	NULL
microgram	NULL
of	NULL
cell	NULL
protein	NULL
to	NULL
each	NULL
construct	NULL
transiently	NULL
expressed	NULL
in	NULL
Eahy926	NULL
cells	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
or	NULL
TRAP	NULL
(	NULL
25	NULL
uM	NULL
)	NULL
are	NULL
given	NULL
at	NULL
right	NULL
.	NULL

Luciferase	NULL
activity	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
performed	NULL
in	NULL
triplicates	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
thrombin	NULL
and	NULL
TRAP	NULL
on	NULL
ICAM-1-TRE	NULL
driven	NULL
luciferase	NULL
expression	NULL
``	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
Agonist	NULL
(	NULL
RLU/ug	NULL
cell	NULL
protein	NULL
)	NULL
None	NULL
50	NULL
+	NULL
0.37	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
66	NULL
+	NULL
0.36	NULL
TRAP	NULL
(	NULL
25	NULL
uM	NULL
)	NULL
74	NULL
+	NULL
0.30	NULL
``	NULL
Three	NULL
copies	NULL
of	NULL
TRE	NULL
element	NULL
from	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
linked	NULL
to	NULL
-globin	NULL
TATA	NULL
box	NULL
luciferase	NULL
construct	NULL
(	NULL
pICAMTRE1	NULL
)	NULL
(	NULL
36	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
Eahy926	NULL
cell	NULL
using	NULL
lipofectamine	NULL
.	NULL

Cells	NULL
were	NULL
exposed	NULL
to	NULL
thrombin	NULL
or	NULL
TRAP	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
.	NULL

At	NULL
18	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
1	NULL
SE	NULL
;	NULL
n	NULL
=	NULL
4	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

disrupted	NULL
TNF-a	NULL
@	NULL
-induced	NULL
band	NULL
1	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
supershift	NULL
,	NULL
whereas	NULL
Abs	NULL
to	NULL
p50	NULL
or	NULL
p52	NULL
did	NULL
not	NULL
have	NULL
an	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

13B	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
failure	NULL
of	NULL
p50	NULL
or	NULL
other	NULL
Abs	NULL
to	NULL
elicit	NULL
a	NULL
super-shifted	NULL
complex	NULL
is	NULL
the	NULL
result	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
interacting	NULL
at	NULL
the	NULL
ICAM-1	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
rather	NULL
than	NULL
the	NULL
inability	NULL
of	NULL
these	NULL
Abs	NULL
to	NULL
supershift	NULL
under	NULL
the	NULL
conditions	NULL
used	NULL
,	NULL
we	NULL
performed	NULL
another	NULL
control	NULL
experiment	NULL
in	NULL
which	NULL
anti-p50	NULL
indeed	NULL
caused	NULL
a	NULL
supershift	NULL
when	NULL
mixed	NULL
with	NULL
purified	NULL
p50	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
thrombin	NULL
exposure	NULL
of	NULL
HUVEC	NULL
results	NULL
in	NULL
a	NULL
binding	NULL
complex	NULL
(	NULL
as	NULL
evidenced	NULL
by	NULL
band	NULL
1	NULL
)	NULL
containing	NULL
the	NULL
p65	NULL
homodimer	NULL
.	NULL

Discussion	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
the	NULL
serine	NULL
protease	NULL
thrombin	NULL
,	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
its	NULL
cell	NULL
surface	NULL
receptor	NULL
PAR-1	NULL
,	NULL
induces	NULL
ICAM-1	NULL
gene	NULL
expression	NULL
in	NULL
vascular	NULL
endothelial	NULL
cells	NULL
via	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
pathway	NULL
.	NULL

Thrombin	NULL
stim-	NULL
sp1	NULL
c	NULL
w®	NULL
__	NULL
are	NULL
pGL2WT	NULL
>	NULL
KOKO	NULL
-C	NULL
Bo	NULL
+243	NULL
-237	NULL
-223	NULL
+84	NULL
sp1	NULL
ct	NULL
w*	NULL
AP2	NULL
WWC	NULL
pGL2-Sp-1-MU	NULL
-247	NULL
|	NULL
A6	NULL
|_	NULL
uwe	NULL
«	NULL
243	NULL
«	NULL
237	NULL
223	NULL
84	NULL
sp1	NULL
c	NULL
w	NULL
AP2	NULL
pGL2-C/EBP-MU	NULL
47	NULL
[	NULL
K	NULL
[	NULL
[	NULL
O	NULL
I	NULL
_|	NULL
we	NULL
T	NULL
we	NULL
«	NULL
pas	NULL
937	NULL
223	NULL
84	NULL
sp1	NULL
ch	NULL
w*	NULL
AP2	NULL
pGL2-NF-kB-MU	NULL
247	NULL
(	NULL
JO	NULL
~A	NULL
[	NULL
we	NULL
T	NULL
ae	NULL
«	NULL
243	NULL
237	NULL
923	NULL
84	NULL
FIGURE	NULL
10	NULL
.	NULL

5473	NULL
0.100	NULL
[	NULL
___	NULL
]	NULL
Control	NULL
RRB	NULL
Thrombin	NULL
§	NULL
-	NULL
coors	NULL
6	NULL
a	NULL
.	NULL

8	NULL
-	NULL
0.050	NULL
led	NULL
3	NULL
3	NULL
«	NULL
-	NULL
!	NULL

©	NULL
0.025	NULL
0.000	NULL
FIGURE	NULL
11	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
essential	NULL
to	NULL
confer	NULL
thrombin	NULL
inducibility	NULL
.	NULL

HUVEC	NULL
were	NULL
transfected	NULL
with	NULL
pNF-	NULL
«	NULL
B-LUC	NULL
plasmid	NULL
containing	NULL
five	NULL
copies	NULL
of	NULL
NF-KB	NULL
sites	NULL
linked	NULL
to	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

At	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
thrombin	NULL
(	NULL
5	NULL
U/ml	NULL
)	NULL
and	NULL
were	NULL
harvested	NULL
6	NULL
h	NULL
after	NULL
treatment	NULL
,	NULL
and	NULL
cell	NULL
extract	NULL
was	NULL
assessed	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
a	NULL
Turner	NULL
TD	NULL
20/20	NULL
luminometer	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
RLU/ug	NULL
of	NULL
cell	NULL
protein	NULL
.	NULL

Data	NULL
are	NULL
mean	NULL
+	NULL
1	NULL
SE	NULL
;	NULL
n	NULL
=	NULL
6	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

ulation	NULL
of	NULL
HUVEC	NULL
resulted	NULL
in	NULL
increased	NULL
ICAM-1	NULL
mRNA	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
,	NULL
and	NULL
consequently	NULL
ICAM-1-dependent	NULL
PMN	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
ICAM-1	NULL
message	NULL
did	NULL
not	NULL
require	NULL
novel	NULL
protein	NULL
synthesis	NULL
,	NULL
as	NULL
it	NULL
was	NULL
insensitive	NULL
to	NULL
CHX	NULL
.	NULL

The	NULL
mRNA	NULL
expression	NULL
peaked	NULL
between	NULL
2-4	NULL
h	NULL
after	NULL
thrombin	NULL
challenge	NULL
,	NULL
and	NULL
returned	NULL
to	NULL
the	NULL
basal	NULL
level	NULL
by	NULL
24	NULL
h.	NULL
EMSA	NULL
,	NULL
mutation/deletion	NULL
construct	NULL
reporter	NULL
gene	NULL
transfection	NULL
assays	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
experiments	NULL
indicated	NULL
that	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
to	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
mediated	NULL
thrombin-induced	NULL
ICAM-1	NULL
transcription	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
complexes	NULL
containing	NULL
the	NULL
p65	NULL
subunit	NULL
are	NULL
known	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
an	NULL
inflammatory	NULL
response	NULL
.	NULL

C	NULL
--	NULL
Control	NULL
Thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
Luciferase	NULL
Acativity	NULL
(	NULL
Fold	NULL
Increase	NULL
)	NULL
t	NULL
On	NULL
``	NULL
A	NULL
&	NULL
'	NULL
%	NULL
Mutation	NULL
of	NULL
downstream	NULL
NF-KB	NULL
site	NULL
prevents	NULL
thrombin-induced	NULL
ICAM-1	NULL
promoter	NULL
activation	NULL
.	NULL

The	NULL
pGL2-WT	NULL
or	NULL
-MU	NULL
vectors	NULL
containing	NULL
wild-type	NULL
(	NULL
solid	NULL
rectangles	NULL
)	NULL
and	NULL
mutant	NULL
versions	NULL
(	NULL
open	NULL
rectangles	NULL
)	NULL
of	NULL
Sp-1	NULL
(	NULL
pGL2-Sp-1-MU	NULL
)	NULL
,	NULL
C/EBP	NULL
(	NULL
pGL2-C/EBP-1-MU	NULL
)	NULL
,	NULL
and	NULL
the	NULL
downstream	NULL
NF-KB	NULL
(	NULL
pGL2-NF-	NULL
«	NULL
B-MU	NULL
)	NULL
site	NULL
and	NULL
pTKRLUC	NULL
plasmid	NULL
were	NULL
cotransfected	NULL
into	NULL
HUVEC	NULL
using	NULL
superfect	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
pTKRLUC	NULL
plasmid	NULL
contains	NULL
a	NULL
Renilla	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
constitutively	NULL
active	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
.	NULL

At	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
thrombin	NULL
at	NULL
the	NULL
indicated	NULL
concentration	NULL
,	NULL
and	NULL
were	NULL
harvested	NULL
15	NULL
h	NULL
after	NULL
treatment	NULL
,	NULL
and	NULL
cell	NULL
extract	NULL
was	NULL
assessed	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
a	NULL
TD	NULL
20/20	NULL
luminometer	NULL
.	NULL

Firefly	NULL
luciferase	NULL
activity	NULL
normalized	NULL
to	NULL
Renilla	NULL
luciferase	NULL
activty	NULL
is	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
relative	NULL
to	NULL
the	NULL
untreated	NULL
medium	NULL
control	NULL
of	NULL
each	NULL
construct	NULL
.	NULL

Values	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
performed	NULL
in	NULL
triplicates	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5474	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Uh	NULL
ted	NULL
band	NULL
1	NULL
#	NULL
band	NULL
2	NULL
#	NULL
»	NULL
band	NULL
3	NULL
#	NULL
»	NULL
Free	NULL
Probe	NULL
#	NULL
»	NULL
FIGURE	NULL
12	NULL
.	NULL

Thrombin	NULL
induces	NULL
NF-KB	NULL
binding	NULL
to	NULL
ICAM-1	NULL
promoter	NULL
.	NULL

EMSA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
HUVEC	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
(	NULL
Zanes	NULL
3-6	NULL
)	NULL
or	NULL
without	NULL
(	NULL
Zane	NULL
2	NULL
;	NULL
control	NULL
)	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
75-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
wild-type	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
mutant	NULL
ICAM-1	NULL
NF-KB	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
radiolabeled	NULL
wild-type	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
mutant	NULL
ICAM-1	NULL
NF-	NULL
«	NULL
B	NULL
probes	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
no	NULL
extract	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
four	NULL
performed	NULL
is	NULL
shown	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
thrombin	NULL
induction	NULL
of	NULL
the	NULL
ICAM-1	NULL
gene	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
CHX	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
ability	NULL
of	NULL
PDTC	NULL
to	NULL
prevent	NULL
the	NULL
thrombin-induced	NULL
increase	NULL
in	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
,	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
NF-	NULL
«	NULL
B-dependent	NULL
signaling	NULL
pathway	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
slight	NULL
induction	NULL
of	NULL
ICAM-1	NULL
mRNA	NULL
by	NULL
CHX	NULL
alone	NULL
may	NULL
be	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
IxB	NULL
synthesis	NULL
by	NULL
CHX	NULL
and	NULL
is	NULL
characteristic	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
genes	NULL
(	NULL
24	NULL
)	NULL
.	NULL

EMSA	NULL
showed	NULL
that	NULL
thrombin	NULL
induced	NULL
nuclear	NULL
NF-KB	NULL
translocation	NULL
and	NULL
DNA-binding	NULL
activity	NULL
.	NULL

The	NULL
binding	NULL
complex	NULL
consisted	NULL
of	NULL
NF-kB	NULL
p65	NULL
ho-modimer	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
supershift	NULL
experiments	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
either	NULL
by	NULL
blocking	NULL
its	NULL
activation	NULL
and	NULL
thereby	NULL
its	NULL
nuclear	NULL
translocation	NULL
or	NULL
by	NULL
mutating	NULL
the	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
and	NULL
thereby	NULL
preventing	NULL
binding	NULL
of	NULL
activated	NULL
NF-KB	NULL
to	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
,	NULL
abolished	NULL
thrombin-induced	NULL
increase	NULL
in	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
and	NULL
ICAM-1	NULL
promoter	NULL
activity	NULL
,	NULL
respectively	NULL
.	NULL

Studies	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mediates	NULL
a	NULL
number	NULL
of	NULL
thrombin-induced	NULL
cellular	NULL
responses	NULL
such	NULL
as	NULL
proliferation	NULL
and	NULL
cy-tokine	NULL
production	NULL
in	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
37	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
requires	NULL
the	NULL
phosphorylation	NULL
either	NULL
on	NULL
serine	NULL
or	NULL
A	NULL
FIGURE	NULL
13	NULL
.	NULL

Thrombin	NULL
induces	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
to	NULL
the	NULL
downstream	NULL
NF-KB	NULL
site	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
.	NULL

EMSA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
HUVEC	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
thrombin	NULL
(	NULL
2.5	NULL
U/ml	NULL
)	NULL
(	NULL
A	NULL
,	NULL
lanes	NULL
3-8	NULL
)	NULL
or	NULL
TNF-a	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
(	NULL
B	NULL
,	NULL
lanes	NULL
2-6	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
rabbit	NULL
Abs	NULL
specific	NULL
for	NULL
A	NULL
,	NULL
p50	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
cRel	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
RelB	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
;	NULL
or	NULL
B	NULL
,	NULL
p50	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
p50	NULL
+	NULL
p65	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
p52	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
addition	NULL
of	NULL
radiolabeled	NULL
ICAM-1	NULL
NF-KB	NULL
probe	NULL
.	NULL

A	NULL
,	NULL
Lane	NULL
1	NULL
,	NULL
no	NULL
extract	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
extract	NULL
from	NULL
control	NULL
untreated	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
Lane	NULL
1	NULL
,	NULL
extract	NULL
from	NULL
control	NULL
untreated	NULL
cells	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
five	NULL
performed	NULL
is	NULL
shown	NULL
.	NULL

Thrombin	NULL
Antibody	NULL
Ek	NULL
p65/p6	NULL
$	NULL
i	NULL
»	NULL
Free	NULL
Probe	NULL
&	NULL
=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
THROMBIN	NULL
ACTIVATES	NULL
NF-	NULL
«	NULL
kBp65	NULL
AND	NULL
ICAM-1	NULL
EXPRESSION	NULL
tyrosine	NULL
residues	NULL
of	NULL
IB	NULL
,	NULL
which	NULL
sequesters	NULL
NF-KB	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

Many	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
activators	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induce	NULL
serine	NULL
phosphorylation	NULL
of	NULL
IB	NULL
that	NULL
targets	NULL
it	NULL
for	NULL
rapid	NULL
polyubiquitination	NULL
,	NULL
followed	NULL
by	NULL
degradation	NULL
through	NULL
2658	NULL
proteasome	NULL
(	NULL
28-31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
certain	NULL
settings	NULL
such	NULL
as	NULL
reoxygenation	NULL
of	NULL
hypoxic	NULL
cells	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
leads	NULL
to	NULL
NF-KB	NULL
activation	NULL
without	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
32	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
exclude	NULL
any	NULL
of	NULL
these	NULL
possible	NULL
mechanisms	NULL
for	NULL
NF-KB	NULL
activation	NULL
following	NULL
thrombin	NULL
stimulation	NULL
of	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
TNF-	NULL
«	NULL
or	NULL
IL-1	NULL
activates	NULL
ICAM-1	NULL
expression	NULL
via	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
TNE-	NULL
&	NULL
-	NULL
or	NULL
IL-B-induced	NULL
ICAM-1	NULL
expression	NULL
is	NULL
rapid	NULL
,	NULL
with	NULL
mRNA	NULL
being	NULL
detectable	NULL
as	NULL
early	NULL
as	NULL
0.5	NULL
h	NULL
,	NULL
peaking	NULL
at	NULL
steady	NULL
state	NULL
level	NULL
by	NULL
2	NULL
h	NULL
(	NULL
49	NULL
)	NULL
as	NULL
opposed	NULL
to	NULL
thrombin-induced	NULL
ICAM-1	NULL
mRNA	NULL
expression	NULL
,	NULL
which	NULL
peaks	NULL
between	NULL
2-4	NULL
h	NULL
,	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
thrombin	NULL
response	NULL
may	NULL
be	NULL
secondary	NULL
to	NULL
TNF-a	NULL
or	NULL
IL-1	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
such	NULL
a	NULL
possibility	NULL
is	NULL
ruled	NULL
out	NULL
by	NULL
the	NULL
findings	NULL
that	NULL
thrombin	NULL
response	NULL
was	NULL
not	NULL
prevented	NULL
by	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
CHX	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Kaplanski	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
receptor	NULL
antagonist	NULL
,	NULL
Abs	NULL
,	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
IL-1	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
IL-1a	NULL
@	NULL
failed	NULL
to	NULL
inhibit	NULL
thrombin-induced	NULL
E-selectin	NULL
and	NULL
IL-8	NULL
gene	NULL
expression	NULL
in	NULL
HUVEC	NULL
.	NULL

Furthermore	NULL
,	NULL
IL-1	NULL
«	NULL
&	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
@	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
thrombin-activated	NULL
HUVEC	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
showed	NULL
that	NULL
deletion	NULL
of	NULL
upstream	NULL
NF-KB	NULL
site	NULL
(	NULL
-533	NULL
bases	NULL
from	NULL
translation	NULL
start	NULL
site	NULL
)	NULL
did	NULL
not	NULL
prevent	NULL
the	NULL
thrombin	NULL
response	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
did	NULL
not	NULL
examine	NULL
whether	NULL
this	NULL
site	NULL
can	NULL
bind	NULL
p65	NULL
homodimer	NULL
in	NULL
response	NULL
to	NULL
thrombin	NULL
or	NULL
TRAP	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
thrombin-responsive	NULL
region	NULL
(	NULL
spanning	NULL
from	NULL
-393	NULL
to	NULL
-176	NULL
bases	NULL
from	NULL
the	NULL
start	NULL
codon	NULL
)	NULL
contained	NULL
AP-1/TRE	NULL
,	NULL
SP1	NULL
,	NULL
C/EBP	NULL
,	NULL
and	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
this	NULL
region	NULL
revealed	NULL
that	NULL
TRE	NULL
by	NULL
itself	NULL
is	NULL
not	NULL
functionally	NULL
important	NULL
for	NULL
thrombin	NULL
activation	NULL
of	NULL
ICAM-1	NULL
gene	NULL
;	NULL
however	NULL
,	NULL
we	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
it	NULL
may	NULL
cooperate	NULL
with	NULL
other	NULL
cis-acting	NULL
elements	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
mediate	NULL
thrombin	NULL
response	NULL
.	NULL

Interest-ingly	NULL
,	NULL
the	NULL
close	NULL
arrangement	NULL
of	NULL
C/EBP	NULL
and	NULL
NF-KB	NULL
binding	NULL
sites	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
promoter	NULL
(	NULL
50	NULL
)	NULL
.	NULL

These	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
mediation	NULL
of	NULL
TNF-	NULL
«	NULL
signal	NULL
to	NULL
the	NULL
ICAM-1	NULL
promoter	NULL
(	NULL
22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
C/EBP	NULL
or	NULL
Sp-1	NULL
site	NULL
failed	NULL
to	NULL
prevent	NULL
thrombin-induced	NULL
activation	NULL
of	NULL
ICAM-1	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
sites	NULL
are	NULL
not	NULL
necessary	NULL
to	NULL
confer	NULL
thrombin	NULL
inducibility	NULL
of	NULL
ICAM-1	NULL
gene	NULL
.	NULL

Mutation	NULL
of	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
abrogated	NULL
the	NULL
response	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
downstream	NULL
NF-B	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
B	NULL
TNFa	NULL
-	NULL
+	NULL
+	NULL
++	NULL
+	NULL
202	NULL
t	NULL
to	NULL
+	NULL
+	NULL
++	NULL
i	NULL
led	NULL
bug	NULL
?	NULL

»	NULL
8	NULL
i	NULL
&	NULL
.9	NULL
s	NULL
5	NULL
&	NULL
8	NULL
.R	NULL
§	NULL
§	NULL
§	NULL
8	NULL
1	NULL
_	NULL
Antibody	NULL
|	NULL
-	NULL
-	NULL
€	NULL
€	NULL
SS	NULL
#	NULL
>	NULL
Free	NULL
Probe	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
thrombin-mediated	NULL
ICAM-1	NULL
gene	NULL
transcription	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
thrombin	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
B-mediated	NULL
activation	NULL
of	NULL
a	NULL
minimal	NULL
heterologous	NULL
promoter	NULL
established	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
essential	NULL
for	NULL
ICAM-1	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
)	NULL
.	NULL

The	NULL
downstream	NULL
NF-KB	NULL
site	NULL
is	NULL
also	NULL
necessary	NULL
for	NULL
hypoxia-in-duced	NULL
cyclooxygenase-2	NULL
(	NULL
COX-2	NULL
)	NULL
expression	NULL
in	NULL
HUVEC	NULL
.	NULL

Human	NULL
COX-2	NULL
promoter	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
:	NULL
the	NULL
upstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
5-GGGGATTCCC-3	NULL
'	NULL
,	NULL
-445	NULL
bp	NULL
relative	NULL
to	NULL
transcriptional	NULL
start	NULL
site	NULL
)	NULL
and	NULL
the	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
5'-GGGGACTACC-3	NULL
'	NULL
,	NULL
-223	NULL
bp	NULL
relative	NULL
to	NULL
transcriptional	NULL
start	NULL
site	NULL
)	NULL
.	NULL

Schmedtj	NULL
et	NULL
al	NULL
.	NULL

(	NULL
51	NULL
)	NULL
have	NULL
reported	NULL
recently	NULL
that	NULL
the	NULL
downstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
of	NULL
COX-2	NULL
promoter	NULL
is	NULL
necessary	NULL
for	NULL
hy-poxia-mediated	NULL
COX-2	NULL
gene	NULL
transcription	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
upstream	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
has	NULL
no	NULL
effect	NULL
.	NULL

PMN	NULL
sequestration	NULL
into	NULL
the	NULL
extravascular	NULL
space	NULL
is	NULL
mediated	NULL
by	NULL
not	NULL
only	NULL
the	NULL
action	NULL
of	NULL
chemotactic	NULL
agents	NULL
,	NULL
but	NULL
also	NULL
by	NULL
PMN	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
(	NULL
52	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
thrombin	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
PMN	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
through	NULL
P-selectin	NULL
(	NULL
CD62P	NULL
)	NULL
and	NULL
ICAM-1	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
this	NULL
phenomenon	NULL
is	NULL
rapid	NULL
(	NULL
occurring	NULL
within	NULL
0.5	NULL
h	NULL
)	NULL
and	NULL
does	NULL
not	NULL
involve	NULL
induction	NULL
of	NULL
mRNAs	NULL
for	NULL
ICAM-1	NULL
and	NULL
P-selectin	NULL
,	NULL
and	NULL
occurred	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
delayed	NULL
thrombin	NULL
response	NULL
(	NULL
occurring	NULL
after	NULL
2	NULL
h	NULL
)	NULL
resulted	NULL
in	NULL
further	NULL
increase	NULL
in	NULL
PMN	NULL
adhesion	NULL
and	NULL
required	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
of	NULL
ICAM-1	NULL
.	NULL

Thrombin	NULL
also	NULL
induces	NULL
both	NULL
IL-8	NULL
and	NULL
E-selectin	NULL
(	NULL
CD62E	NULL
)	NULL
gene	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
with	NULL
similar	NULL
kinetics	NULL
as	NULL
that	NULL
of	NULL
ICAM-1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
in	NULL
the	NULL
sequence	NULL
of	NULL
adhesion	NULL
events	NULL
,	NULL
E-selectin	NULL
mediates	NULL
PMN	NULL
rolling	NULL
,	NULL
whereas	NULL
ICAM-1	NULL
contributes	NULL
to	NULL
firm	NULL
arrest	NULL
and	NULL
IL-8	NULL
promotes	NULL
transmigration	NULL
of	NULL
PMN	NULL
across	NULL
endothelial	NULL
cells	NULL
;	NULL
hence	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
thrombin	NULL
to	NULL
induce	NULL
these	NULL
genes	NULL
correlates	NULL
with	NULL
the	NULL
findings	NULL
that	NULL
thrombin	NULL
infusion	NULL
produced	NULL
PMN	NULL
sequestration	NULL
in	NULL
pulmonary	NULL
mi-crovessels	NULL
secondary	NULL
to	NULL
the	NULL
attachment	NULL
of	NULL
PMN	NULL
to	NULL
vascular	NULL
endothelial	NULL
cells	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

The	NULL
resultant	NULL
vascular	NULL
injury	NULL
and	NULL
tissue	NULL
inflammation	NULL
were	NULL
critically	NULL
dependent	NULL
on	NULL
ICAM-1-mediated	NULL
PMN	NULL
adhesion	NULL
to	NULL
microvessel	NULL
endothelial	NULL
cells	NULL
(	NULL
55	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
role	NULL
in	NULL
intravascular	NULL
coagulation	NULL
,	NULL
thrombin	NULL
serves	NULL
as	NULL
a	NULL
critical	NULL
mediator	NULL
of	NULL
the	NULL
inflammatory	NULL
process	NULL
through	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
Bp65	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
ICAM-1	NULL
and	NULL
ICAM-1-dependent	NULL
endothelial	NULL
adhesivity	NULL
toward	NULL
PMN	NULL
.	NULL

Thus	NULL
,	NULL
thrombin-induced	NULL
ICAM-1	NULL
expression	NULL
is	NULL
an	NULL
important	NULL
linkage	NULL
between	NULL
the	NULL
coagulation	NULL
cascade	NULL
and	NULL
inflammatory	NULL
response	NULL
,	NULL
which	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
vascular	NULL
endothelial	NULL
adhesivity	NULL
,	NULL
PMN	NULL
adhe-sion	NULL
,	NULL
and	NULL
PMN	NULL
migration	NULL
across	NULL
the	NULL
endothelial	NULL
barrier	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Christian	NULL
Stratowa	NULL
for	NULL
plasmids	NULL
containing	NULL
5	NULL
'	NULL
deletion	NULL
mutation	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
promoter	NULL
,	NULL
and	NULL
Dr.	NULL
Z.	NULL
Cao	NULL
for	NULL
constructs	NULL
with	NULL
mutated	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
,	NULL
CAAT	NULL
enhancer-binding	NULL
pro-tein	NULL
,	NULL
or	NULL
promoter	NULL
selective-1	NULL
site	NULL
in	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
promoter	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
.	NULL

Michael	NULL
Karin	NULL
and	NULL
Elizabeth	NULL
Nabel	NULL
for	NULL
their	NULL
useful	NULL
suggestions	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Robert	NULL
Rothlein	NULL
for	NULL
anti-intercellular	NULL
adhesion	NULL
molecule-1	NULL
antibodies	NULL
(	NULL
RR1/1	NULL
and	NULL
BIRROO0O1	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Fenton	NULL
,	NULL
J.	NULL
W.	NULL
II	NULL
.	NULL

1988	NULL
.	NULL

Thrombin	NULL
bioregulatory	NULL
functions	NULL
.	NULL

Adv	NULL
.	NULL

Clin	NULL
.	NULL

Enzymol	NULL
.	NULL

6:186	NULL
.	NULL

2	NULL
.	NULL

Siess	NULL
,	NULL
W.	NULL
1989	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
of	NULL
platelet	NULL
activation	NULL
.	NULL

Physiol	NULL
.	NULL

Rev	NULL
.	NULL

69	NULL
:	NULL
58	NULL
.	NULL

3	NULL
.	NULL

Bachhuber	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
I.	NULL
J.	NULL
Sarenbock	NULL
,	NULL
L.	NULL
W.	NULL
Gimple	NULL
,	NULL
C.	NULL
A.	NULL
McNamara	NULL
,	NULL
and	NULL
G.	NULL
K.	NULL
Owens	NULL
.	NULL

1995	NULL
.	NULL

Thrombin-induced	NULL
mitogenesis	NULL
in	NULL
cultured	NULL
aortic	NULL
smooth	NULL
muscle	NULL
cells	NULL
requires	NULL
prolonged	NULL
thrombin	NULL
exposure	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

268	NULL
:	NULL
C1141	NULL
.	NULL

4	NULL
.	NULL

Bar-Shavit	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
J.	NULL
Khan	NULL
,	NULL
K.	NULL
G.	NULL
Mann	NULL
,	NULL
and	NULL
G.	NULL
D.	NULL
Wilner	NULL
.	NULL

1986	NULL
.	NULL

Chemotactic	NULL
responses	NULL
of	NULL
monocytes	NULL
to	NULL
thrombin	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

32:261	NULL
.	NULL

5	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

5475	NULL
Pober	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Cotran	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
role	NULL
of	NULL
endothelial	NULL
cells	NULL
in	NULL
inflammation	NULL
.	NULL

Transplantation	NULL
50:537.	NULL
.	NULL

Bach	NULL
,	NULL
F.	NULL
H.	NULL
,	NULL
S.	NULL
C.	NULL
Robson	NULL
,	NULL
C.	NULL
Ferran	NULL
,	NULL
H.	NULL
Winkler	NULL
,	NULL
M.	NULL
T.	NULL
Millan	NULL
,	NULL
K.	NULL
M.	NULL
Stuhlmeier	NULL
,	NULL
B.	NULL
Vanhove	NULL
,	NULL
M.	NULL
L.	NULL
Blakeley	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

Van	NULL
der	NULL
Werf	NULL
,	NULL
E.	NULL
Hofer	NULL
,	NULL
R.	NULL
De	NULL
Martin	NULL
,	NULL
and	NULL
W.	NULL
W.	NULL
Hancock	NULL
.	NULL

1994	NULL
.	NULL

Endothelial	NULL
cell	NULL
activation	NULL
and	NULL
throm-boregulation	NULL
during	NULL
xenograft	NULL
rejection	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

141:5.	NULL
.	NULL

Jaffe	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
A.	NULL
J.	NULL
Grulich	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
Weksler	NULL
,	NULL
G.	NULL
Hampel	NULL
,	NULL
and	NULL
K.	NULL
Watanabe	NULL
.	NULL

1987	NULL
.	NULL

Correlation	NULL
between	NULL
thrombin-induced	NULL
prostacyclin	NULL
production	NULL
and	NULL
inositol	NULL
triphosphate	NULL
and	NULL
cytosolic	NULL
free	NULL
calcium	NULL
levels	NULL
in	NULL
cultured	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:8557.	NULL
.	NULL

Malik	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Fenton	NULL
.	NULL

1992	NULL
.	NULL

Thrombin-mediated	NULL
increase	NULL
in	NULL
endothelial	NULL
permeability	NULL
.	NULL

Semin	NULL
.	NULL

Thromb	NULL
.	NULL

Hemost	NULL
.	NULL

18:193.	NULL
.	NULL

Sugama	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Tirruppathi	NULL
,	NULL
K.	NULL
Janakidevi	NULL
,	NULL
T.	NULL
T.	NULL
Anderson	NULL
,	NULL
J.	NULL
W.	NULL
Fenton	NULL
II	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Malik	NULL
.	NULL

1992	NULL
.	NULL

Thrombin-induced	NULL
expression	NULL
of	NULL
endothelial	NULL
P-selectin	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
stabilizing	NULL
neutrophil	NULL
adhesion	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

199:935	NULL
.	NULL

Zimmerman	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
T.	NULL
M.	NULL
Mcintyre	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Prescott	NULL
.	NULL

1985	NULL
.	NULL

Thrombin	NULL
stimulates	NULL
the	NULL
adherence	NULL
of	NULL
neutrophils	NULL
to	NULL
endothelial	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

76:2235	NULL
.	NULL

Ueno	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Murakani	NULL
,	NULL
K.	NULL
Yamanouchi	NULL
,	NULL
M.	NULL
Watanabe	NULL
,	NULL
and	NULL
T.	NULL
Kondo	NULL
.	NULL

1996	NULL
.	NULL

Thrombin	NULL
stimulates	NULL
production	NULL
of	NULL
interleukin-8	NULL
in	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
.	NULL

Immunology	NULL
88:76	NULL
.	NULL

Kaplanski	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Pabrigoule	NULL
,	NULL
V.	NULL
Boulay	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
P.	NULL
Bougrand	NULL
,	NULL
S.	NULL
Kaplanski	NULL
,	NULL
and	NULL
C.	NULL
Parnarier	NULL
.	NULL

1997	NULL
.	NULL

Thrombin	NULL
induces	NULL
endothelial	NULL
type	NULL
II	NULL
activation	NULL
in	NULL
vitro	NULL
:	NULL
IL-1	NULL
and	NULL
TNFa-independent	NULL
IL-8	NULL
secretion	NULL
and	NULL
E-selectin	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5435	NULL
.	NULL

Marsen	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
S.	NULL
A.	NULL
Simonson	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Dunn	NULL
.	NULL

1995	NULL
.	NULL

Thrombin	NULL
induces	NULL
the	NULL
preproendothelin-1	NULL
gene	NULL
in	NULL
endothelial	NULL
cell	NULL
by	NULL
a	NULL
protein	NULL
tyrosine	NULL
kinase-linked	NULL
pathway	NULL
.	NULL

Circ	NULL
.	NULL

Res	NULL
.	NULL

76:987	NULL
.	NULL

Scarpati	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
DiCorleto	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
thrombin	NULL
response	NULL
clement	NULL
in	NULL
the	NULL
human	NULL
platelet	NULL
derived	NULL
growth	NULL
factor	NULL
B-chain	NULL
(	NULL
c-sis	NULL
)	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:3025	NULL
.	NULL

Anrather	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
T.	NULL
Milan	NULL
,	NULL
A.	NULL
Palmetshofer	NULL
,	NULL
S.	NULL
C.	NULL
Robson	NULL
,	NULL
C.	NULL
Geczy	NULL
,	NULL
A.	NULL
J.	NULL
Ritchie	NULL
,	NULL
F.-H.	NULL
Bach	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Ewenstein	NULL
.	NULL

1997	NULL
.	NULL

Thrombin	NULL
activates	NULL
NF-KB	NULL
and	NULL
potentiates	NULL
endothelial	NULL
cell	NULL
activation	NULL
by	NULL
TNF	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:5620	NULL
.	NULL

Vu	NULL
,	NULL
T.	NULL
K.	NULL
H.	NULL
,	NULL
D.	NULL
T.	NULL
Hung	NULL
,	NULL
V.	NULL
I.	NULL
Wheaton	NULL
,	NULL
and	NULL
S.	NULL
R.	NULL
Coughlin	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
functional	NULL
thrombin	NULL
receptor	NULL
reveals	NULL
a	NULL
novel	NULL
proteolytic	NULL
mechanism	NULL
of	NULL
receptor	NULL
activation	NULL
.	NULL

Cell	NULL
64:1057	NULL
.	NULL

Coughlin	NULL
,	NULL
S.	NULL
R.	NULL
1994	NULL
.	NULL

Protease-activated	NULL
receptors	NULL
start	NULL
a	NULL
family	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:9200	NULL
.	NULL

Gerszten	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
J.	NULL
Chen	NULL
,	NULL
M.	NULL
Ishii	NULL
,	NULL
K.	NULL
Ishii	NULL
,	NULL
L.	NULL
Wang	NULL
,	NULL
T.	NULL
Nanevicz	NULL
,	NULL
C.	NULL
W.	NULL
Truck	NULL
,	NULL
T.	NULL
K.	NULL
H.	NULL
Vu	NULL
,	NULL
and	NULL
S.	NULL
R.	NULL
Coughlin	NULL
.	NULL

1994	NULL
.	NULL

Specificity	NULL
of	NULL
thrombin	NULL
receptor	NULL
for	NULL
agonist	NULL
peptide	NULL
is	NULL
defined	NULL
by	NULL
its	NULL
extracellular	NULL
surfaces	NULL
.	NULL

Nature	NULL
369:648	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
S.	NULL
D.	NULL
Marlin	NULL
,	NULL
R.	NULL
Rothlein	NULL
,	NULL
C.	NULL
Toman	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Anderson	NULL
.	NULL

1989	NULL
.	NULL

Cooperative	NULL
interactions	NULL
of	NULL
LFA-1	NULL
and	NULL
Mac-1	NULL
with	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
in	NULL
facilitating	NULL
adherence	NULL
and	NULL
transendothelial	NULL
migration	NULL
of	NULL
human	NULL
neutrophils	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

83:2008	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
R.	NULL
Rothlein	NULL
,	NULL
B.	NULL
J.	NULL
Hughes	NULL
,	NULL
M.	NULL
M.	NULL
Mariscalo	NULL
,	NULL
H.	NULL
E.	NULL
Rudloff	NULL
,	NULL
F.	NULL
C.	NULL
Schmalsteig	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Anderson	NULL
.	NULL

1988	NULL
.	NULL

Recognition	NULL
of	NULL
an	NULL
endothelial	NULL
determinant	NULL
for	NULL
CD-dependent	NULL
human	NULL
neutrophil	NULL
adherence	NULL
and	NULL
transendothelial	NULL
migration	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

82:1746	NULL
.	NULL

Collins	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
A.	NULL
S.	NULL
Neish	NULL
,	NULL
M.	NULL
Z.	NULL
Whitley	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecules	NULL
:	NULL
NF-kB	NULL
and	NULL
cytokine-inducible	NULL
enhancers	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

9:899	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
V.	NULL
Baichwal	NULL
,	NULL
and	NULL
C.	NULL
Zao	NULL
.	NULL

1994	NULL
.	NULL

Regulatory	NULL
elements	NULL
and	NULL
transcription	NULL
factors	NULL
controlling	NULL
basal	NULL
and	NULL
cytokine-induced	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
ICAM-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:11641	NULL
.	NULL

Ledebur	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
and	NULL
T.	NULL
P.	NULL
Parks	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
by	NULL
inflammatory	NULL
cytokines	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
:	NULL
essential	NULL
roles	NULL
of	NULL
a	NULL
variant	NULL
NF-KB	NULL
site	NULL
and	NULL
p65	NULL
homodimers	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:933	NULL
.	NULL

Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
NF-	NULL
«	NULL
B/rel	NULL
transcription	NULL
factor	NULL
and	NULL
I	NULL
xB	NULL
inhibitor	NULL
system	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5:477	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
:	NULL
structure-function	NULL
relationship	NULL
of	NULL
its	NULL
protein	NULL
subunits	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

290:297	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
D.	NULL
M.	NULL
Rathwarf	NULL
,	NULL
E.	NULL
Zandi	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
cytokine-responsive	NULL
IKB	NULL
kinase	NULL
that	NULL
activates	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
388:548	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
M.	NULL
Rathwarf	NULL
,	NULL
M.	NULL
Delhase	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IkB	NULL
kinase	NULL
complex	NULL
(	NULL
IKK	NULL
)	NULL
contains	NULL
two	NULL
kinase	NULL
subunits	NULL
,	NULL
IKKa	NULL
and	NULL
IKK	NULL
,	NULL
necessary	NULL
for	NULL
I	NULL
xB	NULL
phosphorylation	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

Cell	NULL
91:243	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Sicbenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IkBa	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
V.	NULL
J.	NULL
Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
,	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
I	NULL
kB	NULL
to	NULL
the	NULL
ubiquitinin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
L.	NULL
Parent	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1996	NULL
.	NULL

Site-specific	NULL
phosphorylation	NULL
of	NULL
IkBa	NULL
by	NULL
a	NULL
novel	NULL
ubiquitination-dependent	NULL
protein	NULL
kinase	NULL
activity	NULL
.	NULL

Cell	NULL
84:853	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bauerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IKB	NULL
on	NULL
serine	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IkB	NULL
proteolysis	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2876	NULL
.	NULL

Imbert	NULL
,	NULL
V.	NULL
,	NULL
R.	NULL
A.	NULL
Rupec	NULL
,	NULL
A.	NULL
Livolsi	NULL
,	NULL
H.	NULL
A.	NULL
Pahl	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
Traenckner	NULL
,	NULL
C.	NULL
Muller-Dieckmann	NULL
,	NULL
D.	NULL
Farahifar	NULL
,	NULL
B.	NULL
Rossi	NULL
,	NULL
P.	NULL
Auberger	NULL
,	NULL
P.	NULL
A.	NULL
Bauerle	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Peyron	NULL
.	NULL

1996	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
activates	NULL
NF-B	NULL
without	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Cell	NULL
86:787	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
5476	NULL
33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

Bauerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anru	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
NF-KB	NULL
and	NULL
I	NULL
xB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

Barmes	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
factor-kB	NULL
:	NULL
a	NULL
pivotal	NULL
transcription	NULL
factor	NULL
in	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

336:1066	NULL
.	NULL

Voraberger	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
Schafer	NULL
,	NULL
and	NULL
C.	NULL
Stratowa	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
analysis	NULL
of	NULL
its	NULL
5'-regulatory	NULL
region	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2777	NULL
.	NULL

Maruyama	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
Shigeta	NULL
,	NULL
H.	NULL
Miyahara	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
H.	NULL
Shu	NULL
,	NULL
S.	NULL
Ide	NULL
,	NULL
and	NULL
I.	NULL
Kitajima	NULL
.	NULL

1997	NULL
.	NULL

Thrombin	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
thrombin	NULL
receptor	NULL
and	NULL
results	NULL
in	NULL
proliferation	NULL
of	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
:	NULL
role	NULL
of	NULL
thrombin	NULL
in	NULL
atherosclerosis	NULL
and	NULL
restenosis	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

811:429	NULL
,	NULL
Edgell	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
C.	NULL
C.	NULL
McDonald	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Graham	NULL
.	NULL

1983	NULL
.	NULL

Permanent	NULL
cell	NULL
line	NULL
expressing	NULL
human	NULL
factor	NULL
VIII-related	NULL
antigen	NULL
established	NULL
by	NULL
hybridization	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:3734	NULL
.	NULL

Arai	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
A.	NULL
Kelly	NULL
,	NULL
M.	NULL
L.	NULL
Brengman	NULL
,	NULL
M.	NULL
Takano	NULL
,	NULL
E.	NULL
H.	NULL
Smith	NULL
,	NULL
P.	NULL
J.	NULL
Goldschmidt-Clermont	NULL
,	NULL
and	NULL
G.	NULL
B.	NULL
Bulkley	NULL
.	NULL

1988	NULL
.	NULL

Ambient	NULL
but	NULL
not	NULL
incremental	NULL
oxidant	NULL
generation	NULL
affects	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
induction	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
in	NULL
endothelium	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

331:853	NULL
.	NULL

Staunton	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
S.	NULL
D.	NULL
Marlin	NULL
,	NULL
C.	NULL
Stratowa	NULL
,	NULL
M.	NULL
L.	NULL
Dustin	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1988	NULL
.	NULL

Primary	NULL
structure	NULL
of	NULL
ICAM-1	NULL
demonstrates	NULL
interaction	NULL
between	NULL
members	NULL
of	NULL
the	NULL
immunoglobulin	NULL
and	NULL
integrin	NULL
supergene	NULL
family	NULL
.	NULL

Cell	NULL
52:925	NULL
.	NULL

Roebuck	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
A.	NULL
Rahman	NULL
,	NULL
V.	NULL
Lakshminarayan	NULL
,	NULL
K.	NULL
Janakidevi	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Malik	NULL
.	NULL

1995	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
@	NULL
activate	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
through	NULL
distinct	NULL
cis-regulatory	NULL
elements	NULL
within	NULL
ICAM-1	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:18966	NULL
.	NULL

Rahman	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Kefer	NULL
,	NULL
M.	NULL
Bando	NULL
,	NULL
W.	NULL
D.	NULL
Niles	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Malik	NULL
.	NULL

1998	NULL
.	NULL

E-selectin	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
by	NULL
TNFa-induced	NULL
oxidant	NULL
generation	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

19:1533	NULL
.	NULL

Rothlein	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
M.	NULL
Dustin	NULL
,	NULL
S.	NULL
D.	NULL
Dustin	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
human	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ICAM-1	NULL
)	NULL
distinct	NULL
from	NULL
LFA-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

137:1270	NULL
.	NULL

Pan	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Xia	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
McEver	NULL
.	NULL

1988	NULL
.	NULL

Comparison	NULL
of	NULL
promoters	NULL
for	NULL
murine	NULL
and	NULL
human	NULL
P-selectin	NULL
gene	NULL
suggests	NULL
species-specific	NULL
and	NULL
conserved	NULL
mechanisms	NULL
for	NULL
transcriptional	NULL
regulation	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:10058	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

THROMBIN	NULL
ACTIVATES	NULL
NF-	NULL
«	NULL
kBp65	NULL
AND	NULL
ICAM-1	NULL
EXPRESSION	NULL
Pan	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Xia	NULL
,	NULL
L.	NULL
Yao	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
McEver	NULL
.	NULL

1988	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-a-	NULL
or	NULL
Tipopolysaccharide-induced	NULL
expression	NULL
of	NULL
the	NULL
murine	NULL
P-selectin	NULL
gene	NULL
in	NULL
endothelial	NULL
cells	NULL
involves	NULL
novel	NULL
«	NULL
B	NULL
sites	NULL
and	NULL
a	NULL
variant	NULL
activating	NULL
transcription	NULL
factor/	NULL
cAMP	NULL
response	NULL
clement	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:10068	NULL
.	NULL

Shreck	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Meier	NULL
,	NULL
D.	NULL
Manne	NULL
,	NULL
W.	NULL
Droge	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bauerle	NULL
.	NULL

1992	NULL
.	NULL

Dithiocar-bamate	NULL
as	NULL
potent	NULL
inhibitors	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1181	NULL
.	NULL

Trejo	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
C.	NULL
Chambard	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Brown	NULL
.	NULL

1992	NULL
.	NULL

Biphasic	NULL
increase	NULL
in	NULL
c-jun	NULL
mRNA	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
AP-1	NULL
mediated	NULL
gene	NULL
transcription	NULL
:	NULL
differential	NULL
effects	NULL
of	NULL
muscarinic	NULL
and	NULL
thrombin	NULL
receptor	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4742	NULL
.	NULL

Nakajima	NULL
,	NULL
T.	NULL
,	NULL
L	NULL
Kitajima	NULL
,	NULL
H.	NULL
Shin	NULL
,	NULL
L	NULL
Takasaki	NULL
,	NULL
K.	NULL
Shigeta	NULL
,	NULL
K.	NULL
Abeyama	NULL
,	NULL
Y.	NULL
Yamashita	NULL
,	NULL
T.	NULL
Tokioka	NULL
,	NULL
Y.	NULL
Soejima	NULL
,	NULL
and	NULL
I.	NULL
Maruyama	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
thrombin-induced	NULL
human	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cell	NULL
pro-liferation	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

204:950	NULL
.	NULL

Wertheimer	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
C.	NULL
L.	NULL
Myers	NULL
,	NULL
R.	NULL
W.	NULL
Wallace	NULL
,	NULL
and	NULL
T.	NULL
P.	NULL
Parks	NULL
.	NULL

1992	NULL
.	NULL

Intercellular	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:12030	NULL
.	NULL

Mukaida	NULL
,	NULL
Y.	NULL
,	NULL
Y.	NULL
Mahe	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1990	NULL
.	NULL

Cooperative	NULL
interactions	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
and	NULL
cis-regulatory	NULL
enhancer	NULL
binding	NULL
protein-like	NULL
factor	NULL
binding	NULL
elements	NULL
in	NULL
activating	NULL
the	NULL
interleukin-8	NULL
gene	NULL
by	NULL
pro-inflammatory	NULL
cytokines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:21128	NULL
.	NULL

Schmedtje	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Y.	NULL
S.	NULL
Ji	NULL
,	NULL
W.	NULL
L.	NULL
Liu	NULL
,	NULL
R.	NULL
N.	NULL
DuBois	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Runge	NULL
.	NULL

1997	NULL
.	NULL

Hypoxia	NULL
induces	NULL
cyclooxygenase-2	NULL
via	NULL
the	NULL
NF-kB	NULL
p65	NULL
transcription	NULL
factor	NULL
in	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:601	NULL
.	NULL

Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recirculation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
the	NULL
multistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
76:301.	NULL
Cooper	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
J.	NULL
Solano	NULL
,	NULL
R.	NULL
Bizios	NULL
,	NULL
J.	NULL
E.	NULL
Kaplan	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Malik	NULL
.	NULL

1984	NULL
.	NULL

Pulmonary	NULL
neutrophil	NULL
kinetics	NULL
after	NULL
thrombin-induced	NULL
intravascular	NULL
coagulation	NULL
.	NULL

J.	NULL
Appl	NULL
.	NULL

Physiol	NULL
.	NULL

57:826	NULL
.	NULL

Mailk	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Horgan	NULL
.	NULL

1987	NULL
.	NULL

Mechanisms	NULL
of	NULL
thrombin-induced	NULL
lung	NULL
vascular	NULL
injury	NULL
and	NULL
edema	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

136:464	NULL
.	NULL

Malik	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

1983	NULL
.	NULL

Pulmonary	NULL
microembolism	NULL
.	NULL

Physiol	NULL
.	NULL

Rev	NULL
.	NULL

63:1114	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

